1,450
Views
80
CrossRef citations to date
0
Altmetric
Review Article

Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water

, &
Pages 358-442 | Received 31 Oct 2011, Accepted 06 Mar 2012, Published online: 18 Apr 2012

References

  • Abrahams PW, Follansbee MH, Hunt A, Wragg J. (2006). Iron nutrition and possible lead toxicity: An appraisal of geophagy undertaken by pregnant women of UK Asian countries. Appl Geochem, 21, 98–108.
  • Abreo K, Brown ST, Sella M. (1989). Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate. Am J Kidney Dis 13:465–468.
  • Achard S, Perderiset M, Jaurand MC. (1987). Sister chromatid exchanges in rat pleural mesothelial cells treated with crocidolite, attapulgite, or benzo 3-4 pyrene. Br J Ind Med 44:281–283.
  • Ackley DC, Yokel RA. (1997). Aluminum citrate is transported from brain into blood via the monocarboxylic acid transporter located at the blood-brain barrier. Toxicology 120:89–97.
  • Ackley DC, Yokel RA. (1998). Aluminum transport out of brain extracellular fluid is proton dependent and inhibited by mersalyl acid, suggesting mediation by the monocarboxylate transporter (MCT1). Toxicology 127:59–67.
  • Adler AJ, Caruso C, Berlyne GM. (1991). Effect of aluminum on calcium binding to bovine intestinal calcium-binding protein. Miner Electrolyte Metab 17:141–146.
  • Afriyie-Gyawu E, Mackie J, Dash B, Wiles M, Taylor J, Huebner H, Tang L, Guan H, Wang JS, Phillips T. (2005). Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam 22:259–269.
  • Afriyie-Gyawu E, Ankrah NA, Huebner HJ, Ofosuhene M, Kumi J, Johnson NM, Tang L, Xu L, Jolly PE, Ellis WO, Ofori-Adjei D, Williams JH, Wang JS, Phillips TD. (2008). NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:76–87.
  • Agarwal SK, Ayyash L, Gourley CS, Levy J, Faber K, Hughes CL Jr. (1996). Evaluation of the developmental neuroendocrine and reproductive toxicology of aluminium. Food Chem Toxicol 34:49–53.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (2008). Toxicological Profile for Aluminum. 357 pp. September 2008. Atlanta: U.S. Department of Health and Human Services, Public Health Service. Available at: http://www.atsdr.cdc.gov/ToxProfiles/tp22.pdf.
  • Ahn HW, Fulton B, Moxon D, Jeffery EH. (1995). Interactive effects of fluoride and aluminum uptake and accumulation in bones of rabbits administered both agents in their drinking water. J Toxicol Environ Health 44:337–350.
  • Ahn HW, Jeffery EH. (1994). Effect of aluminum on fluoride uptake by Salmonella typhimurium TA98; implications for the Ames mutagenicity assay. J Toxicol Environ Health 41:357–368.
  • Akyol A, Boyvat A, Kundakçi N. (2004). Contact sensitivity to aluminum. Int J Dermatol 43:942–943.
  • Alfrey AC, Hegg A, Craswell P. (1980). Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 33:1509–1516.
  • Alfrey AC, LeGendre GR, Kaehny WD. (1976). The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184–188.
  • Alfrey AC, Mishell JM, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH. (1972). Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18:257–61, 266.
  • Allen WM, Sansom BF. (1989). Accidental contamination of the public water supply at Lowermoor, Camelford: an assessment of the possible veterinary consequences. Vet Rec 124:479–482.
  • Al-Futaisi A, Al-Jamrah A, Al-Rawas A. (2005). Evaluation of the potential of using an Omani attapulgite as a sorbent in treatment of contaminated water. Ninth Intl. Water Technology Conf. IWTC9, Sharm El-Seikh, Egypt.
  • Al-Rmalli SW, Jenkins RO, Watts MJ, Haris PI. (2010). Risk of human exposure to arsenic and other toxic elements from geophagy: trace element analysis of baked clay using inductively coupled plasma mass spectrometry. Environ Health 9:79.
  • Altekruse EB, Chaudhary BA, Pearson MG, Morgan WK. (1984). Kaolin dust concentrations and pneumoconiosis at a kaolin mine. Thorax 39:436–441.
  • Altmann P, Cunningham J, Dhanesha U, Ballard M, Thompson J, Marsh F. (1999). Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. BMJ 319:807–811.
  • Altmann P, Cunningham J, Marsh F, Dhanesha U, Ballard M, Thompson J. (2000). Authors’ reply to Camelford letters. Br Med J, 320(7248), 156.
  • Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippi A, Gandolfo C, Bino G. (1986). Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of an Italian population. Neurology 36:922–931.
  • American National Standards Institute (ANSI). (1981). American National Standard for Hemodialysis Systems RD5-1981.
  • American Society of Hospital Pharmacists. (1984). Washington, D.C.: American Hospital Formulary Service.
  • American Water Works Association (AWWA). (2009). AWWA Standard for Aluminum Sulfate − Liquid, Ground or Lump. ANSI/AWWA B403-82. Denver. Available at: http://apps.awwa.org/EbusMain/Default.aspx?TabID = 55&ProductId = 6780.
  • Andreoli SP. (1990). Aluminum levels in children with chronic renal failure who consume low-phosphorus infant formula. J Pediatr 116:282–285.
  • Andreoli SP, Goodman WG, Salusky IB. (1990). Reply. J Pediatr, 117, 1008–1009.
  • Andreoli SP, Bergstein JM, Sherrard DJ. (1984). Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310:1079–1084.
  • Andress D, Felsenfeld AJ, Voigts A, Llach F. (1983). Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int 24:364–370.
  • Andress DL, Ott SM, Maloney NA, Sherrard DJ. (1985). Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med 312:468–473.
  • Andress DL, Maloney NA, Endres DB, Sherrard DJ. (1986). Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J Bone Miner Res 1:391–398.
  • Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ. (1987). Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. J Clin Endocrinol Metab 65:11–16.
  • Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ. (1987). Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 316:292–296.
  • Andress DL, Nebeker HG, Ott SM, Endres DB, Alfrey AC, Slatopolsky EA, Coburn JW, Sherrard DJ. (1987). Bone histologic response to deferoxamine in aluminum-related bone disease. Kidney Int 31:1344–1350.
  • Anthone S, Ambrus CM, Kohli R, Min I, Anthone R, Stadler A, Stadler I, Vladutiu A. (1995). Treatment of aluminum overload using a cartridge with immobilized desferrioxamine. J Am Soc Nephrol 6:1271–1277.
  • Arieff AI, Cooper JD, Armstrong D, Lazarowitz VC. (1979). Dementia, renal failure, and brain aluminum. Ann Intern Med 90:741–747.
  • Armstrong BG, Tremblay CG, Cyr D, Thériault GP. (1986). Estimating the relationship between exposure to tar volatiles and the incidence of bladder cancer in aluminum smelter workers. Scand J Work Environ Health 12:486–493.
  • Bache CA, Rutzke M, List DJ. (1991). Absorption of vanadium, nickel, aluminum and molybdenum by Swiss chard grown on soil amended with oil fly ash or bottom ash. J Food Safety, 12, 79–84.
  • Bajaj AK, Gupta SC, Pandey RK, Misra K, Rastogi S, Chatterji AK. (1997). Aluminium contact sensitivity. Contact Derm 37:307–308.
  • Bakir AA, Hryhorczuk DO, Berman E, Dunea G. (1986). Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. ASAIO Trans 32:171–176.
  • Barrett RE. (1972). Dementia in adults. Med Clin North Am 56:1405–1418.
  • Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL. (2006). Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 63:63–72.
  • BASF. (2011). Colloidal hydrated magnesium alumino-silicate. Available at: http://www.supmat.com/downloadBASF/Attapulgite%20Final%2011.15.2007.pdf
  • Bataineh H, Al-Hamood MH, Elbetieha AM. (1998). Assessment of aggression, sexual behavior and fertility in adult male rat following long-term ingestion of four industrial metals salts. Hum Exp Toxicol 17:570–576.
  • Bates D, Parkinson IM, Ward MK, Kerr DN. (1985). Aluminium encephalopathy. Contrib Nephrol 45:29–41.
  • Baydar T, Papp A, Aydin A, Nagymajtenyi L, Schulz H, Isimer A, Sahin G. (2003). Accumulation of aluminum in rat brain: does it lead to behavioral and electrophysiological changes? Biol Trace Elem Res 92:231–244.
  • Bellows CG, Heersche JN, Aubin JE. (1999). Aluminum accelerates osteoblastic differentiation but is cytotoxic in long-term rat calvaria cell cultures. Calcif Tissue Int 65:59–65.
  • Benett RW, Persaud TV, Moore KL. (1975). Experimental studies on the effects of aluminum on pregnancy and fetal development. Anat Anz 138:365–378.
  • Benson RL, Worsfold PJ, Sweeting FW. (1990). On-line determination of residual aluminum in potable and treated waters by flow-injection analysis. Anal Chim Acta, 238, 177–182.
  • Berend K, Trouwborst T. (1999). Cement-mortar pipes as a source of aluminum. J AWWA, 91, 91–100.
  • Berend K, van der Voet G, Boer WH. (2001). Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Int 59:746–753.
  • Bergfors E, Björkelund C, Trollfors B. (2005). Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines. Eur J Pediatr 164:691–697.
  • Bergfors E, Trollfors B, Inerot A. (2003). Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer. Vaccine 22:64–69.
  • Berlyne GM, Ben-Ari J, Pest D, Weinberger J, Stern M, Levine R, Gilmore GR. (1970). Hyperaluminaemia from aluminum resins in renal failure. Lancet 2:494–496.
  • Berlyne GM, Yagil R, Ben-Ari J, Danovitch GM. (1972). Aluminium toxicity. Lancet 1:1070–1071.
  • Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM. (1972). Aluminium toxicity in rats. Lancet 1:564–568.
  • Bernuzzi V, Desor D, Lehr PR. (1986). Effects of prenatal aluminum exposure on neuromotor maturation in the rat. Neurobehav Toxicol Teratol 8:115–119.
  • Bertholf RL, Herman MM, Savory J, Carpenter RM, Sturgill BC, Katsetos CD, Vandenberg SR, Wills MR. (1989). A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol Appl Pharmacol 98:58–74.
  • Bignon J, Sebastien P, Gaudichet A, Jaurand MC. (1980). Biological effects of attapulgite. IARC Sci Publ 163–181.
  • Bilkei-Gorzó A. (1993). Neurotoxic effect of enteral aluminium. Food Chem Toxicol 31:357–361.
  • Bishop NJ. (1989). Personal communication. Cited in Fruendlich M et al., 1990.
  • Bishop NJ, Robinson MJ, Lendon M, Hewitt CD, Day JP, O’Hara M. (1989). Increased concentration of aluminium in the brain of a parenterally fed preterm infant. Arch Dis Child 64:1316–1317.
  • Black RA, Hill DA. (2003). Over-the-counter medications in pregnancy. Am Fam Physician 67:2517–2524.
  • Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teitelbaum SL. (1989). Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01. Kidney Int 35:1119–1125.
  • Bloom WL, Flinchum D. (1960). Osteomalacia with pseudofractures caused by the ingestion of aluminum hydroxide. JAMA, 174, 1327–1330.
  • Böhler-Sommeregger K, Lindemayr H. (1986). Contact sensitivity to aluminium. Contact Derm 15:278–281.
  • Bonna RJ, Aulerich RJ, Bursian SJ, Poppenga RH, Braselton WE, Watson GL. (1991). Efficacy of hydrated sodium calcium aluminosilicate and activated charcoal in reducing the toxicity of dietary aflatoxin to mink. Arch Environ Contam Toxicol 20:441–447.
  • Bornemann A, Bohl J, Schneider HM, Goebel HH, Schmidt PF, Gherardi RK. (2004). July 2003: 62-year-old female with progressive muscular weakness. Brain Pathol 14:109–10, 115.
  • Boudey M, Bureau F, Placé C, Neuville D, Drosdowsky M, Arhan P, Bouglé D. (1997). Effect of small variations of aluminum intake on calcium metabolism in young rats. J Pediatr Gastroenterol Nutr 24:124–127.
  • Bougle D, Bureau F, Voirin J, Neuville D, Duhamel JF. (1992). A cross-sectional study of plasma and urinary aluminum levels in term and preterm infants. JPEN J Parenter Enteral Nutr 16:157–159.
  • Bourdeau A, Plachot JJ, Cournot G, Pointillart A, Sachs C, Balsan S. (1984). In vitro effects of aluminum on parathyroid glands: Correspondence between hormonal secretion and ultrastructural aspects. In: Cohn DV, Fujita T, Potts JT, Talmage RV, eds. Endocrine control of bone and calcium metabolism. Amsterdam: Elsevier, 230–231.
  • Bowdler NC, Beasley DS, Fritze EC, Goulette AM, Hatton JD, Hession J, Ostman DL, Rugg DJ, Schmittdiel CJ. (1979). Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol Biochem Behav 10:505–512.
  • Boyce BF, Eider HY, Fell SG, Nicholson WA, Smith GD, Dempster DW, Gray CC, Boyle IT. (1981). Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy. Scan Electron Microsc 3:329–337.
  • Boyd EM, Covert EL, Shanas MN. (1965). Death from bowel obstruction due to intragastrically administered kaolin. Ind Med Surg 34:874–880.
  • Bozynski ME, Sedman AB, Naglie RA, Wright EJ. (1989). Serial plasma and urinary aluminum levels and tissue loading in preterm twins. JPEN J Parenter Enteral Nutr 13:428–431.
  • Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, Williams J, Buckland PR, Owen MJ, O’Donovan MC. (2004). Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum Mol Genet 13:2885–2892.
  • Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC. (1990). A case-control study of Alzheimer’s disease in Australia. Neurology 40:1698–1707.
  • Brown S, Mendoza N, Bertholf RL, Ross R, Wills MR, Savory J, Krantz KD. (1986). Absorption of aluminum from aceglutamide aluminum in healthy adult males. Res Commun Chem Pathol Pharmacol 53:105–116.
  • Burgess E. (1991). Aluminum toxicity from oral sucralfate therapy. Nephron 59:523–524.
  • Burgess E, Muruve D, Audette R. (1992). Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency. Am J Med 92:471–475.
  • Burnatowska-Hledin MA, Mayor GH. (1984). The effects of sucralfate ingestion on serum and specific tissue aluminum concentration in normal rats. J Toxicol Clin Toxicol 22:87–93.
  • Bursian SJ, Aulerich RJ, Cameron JK, Ames NK, Steficek BA. (1992). Efficacy of hydrated sodium calcium aluminosilicate in reducing the toxicity of dietary zearalenone to mink. J Appl Toxicol 12:85–90.
  • Burwen DR, Olsen SM, Bland LA, Arduino MJ, Reid MH, Jarvis WR. (1995). Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. Kidney Int 48:469–474.
  • Bye GC. (1999). Portland Cement: Composition, Production and Properties. 2nd edition. London: Thomas Telford Ltd.
  • Cam JM, Luck VA, Eastwood JB, de Wardener HE. (1976). The effect of aluminium hydroxide orally on calcium, phosphorus and aluminium metabolism in normal subjects. Clin Sci Mol Med 51:407–414.
  • Cannata JB, Briggs JD, Junor BJ, Fell GS. (1983). Aluminium hydroxide intake: real risk of aluminium toxicity. Br Med J (Clin Res Ed) 286:1937–1938.
  • Cannata JB, Fernández-Soto I, Fernández-Menendez MJ, Fernández-Martín JL, McGregor SJ, Brock JH, Halls D. (1991). Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 39:799–803.
  • Cannata JB, Olaizola IR, Gomez-Alonso C, Menéndez-Fraga P, Alonso-Suarez M, Diaz-Lopez JB. (1993). Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism. Nephron 65:141–146.
  • Cannata JB, Ruiz Alegria P, Cuesta MV, Herrera J, Peral V. (1983). Influence of aluminium hydroxide intake on haemoglobin concentrations and blood transfusion requirements in haemodialysis patients. Proc Eur Dial Transplant Assoc 20:719–724.
  • Cannata-Andía JB, Fernández-Martín JL. (2002). The clinical impact of aluminium overload in renal failure. Nephrol Dial Transplant 17 Suppl 2:9–12.
  • Cappell MS. (2003). Gastric and duodenal ulcers during pregnancy. Gastroenterol Clin North Am 32:263–308.
  • Carmichael KA, Fallon MD, Dalinka M, Kaplan FS, Axel L, Haddad JG. (1984). Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid. Am J Med 76:1137–1143.
  • Carretero IM. (2002). Clay minerals and their beneficial effects upon human health. A review. Appl Clay Sci, 21, 155–163.
  • Carrillo F, Perez C, Camara C. (1992). Sensitive flow-injection-spectrofluorimetric method to determine aluminum III in water. Anal Chim Acta, 262, 91–96.
  • Castelain PY, Castelain M, Vervloet D, Garbe L, Mallet B. (1988). Sensitization to aluminium by aluminium-precipitated dust and pollen extracts. Contact Derm 19:58–60.
  • Cefali EA, Nolan JC, McConnell WR, Walters DL. (1995). Pharmacokinetic study of zeolite A, sodium aluminosilicate, magnesium silicate, and aluminum hydroxide in dogs. Pharm Res 12:270–274.
  • Chan YL, Alfrey AC, Posen S, Lissner D, Hills E, Dunstan CR, Evans RA. (1983). Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35:344–351.
  • Charhon SA, Chavassieux PM, Meunier PJ, Accominotti M. (1985). Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis. Br Med J (Clin Res Ed) 290:1613–1614.
  • Chazan JA, Lew NL, Lowrie EG. (1991). Increased serum aluminum. An independent risk factor for mortality in patients undergoing long-term hemodialysis. Arch Intern Med 151:319–322.
  • Chedid F, Fudge A, Teubner J, James SL, Simmer K. (1991). Aluminium absorption in infancy. J Paediatr Child Health 27:164–166.
  • Chemicalland. (2011). On-line database. Available at: http://www.chemicalland21.com.
  • Chen WJ, Monnat RJ Jr, Chen M, Mottet NK. (1978). Aluminum induced pulmonary granulomatosis. Hum Pathol 9:705–711.
  • Chines A, Pacifici R. (1990). Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int 47:291–295.
  • Cho S, Joshi JG. (1988). Effect of long-term feeding of aluminium chloride on hexokinase and glucose-6-phosphate dehydrogenase in the brain. Toxicology 48:61–69.
  • Chopra JS, Kalra OP, Malik VS, Sharma R, Chandna A. (1986). Aluminium phosphide poisoning: a prospective study of 16 cases in one year. Postgrad Med J 62:1113–1115.
  • Clark RN, King TVV, Klejwa M, Swayze G, Vergo N. (1990). High spectral resolution reflectance spectroscopy of minerals. J Geophys Res, 12653–12680.
  • Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55:1449–1455.
  • Clauberg M, Joshi JG. (1992). Effects of prolonged chronic dietary treatment with AlCl3 on selected metabolisms and memory in rats. Ann N Y Acad Sci 648:289–290.
  • Clauberg M, Smith CB, Dang T, Sokoloff L, Joshi JG. (1994). Effects of chronic dietary aluminum on local cerebral glucose utilization in rats. Neurobiol Aging 15:657–661.
  • Clemmensen O, Knudsen HE. (1980). Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Derm 6:305–308.
  • Coburn JW, Mischel MG, Goodman WG, Salusky IB. (1991). Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis, 17, 708–711.
  • Cohn AL, White AS, Weyrauch HB. (1941). Kaolin granuloma of the stomach. J Amer Med Assoc, 117:2225–2227.
  • Cointry GR, Capozza RF, Negri AL, Ferretti JL. (2005). Biomechanical impact of aluminum accumulation on the pre- and post-yield behavior of rat cortical bone. J Bone Miner Metab 23:15–23.
  • Colomina MT, Esparza JL, Corbella J, Domingo JL. (1998). The effect of maternal restraint on developmental toxicity of aluminum in mice. Neurotoxicol Teratol 20:651–656.
  • Colomina MT, Gómez M, Domingo JL, Corbella J. (1994). Lack of maternal and developmental toxicity in mice given high doses of aluminium hydroxide and ascorbic acid during gestation. Pharmacol Toxicol 74:236–239.
  • Colomina MT, Roig JL, Torrente M, Vicens P, Domingo JL. (2005). Concurrent exposure to aluminum and stress during pregnancy in rats: Effects on postnatal development and behavior of the offspring. Neurotoxicol Teratol 27:565–574.
  • Colomina MT, Roig JL, Sánchez DJ, Domingo JL. (2002). Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology 23:775–781.
  • Combarros O, Alvarez-Arcaya A, Sánchez-Guerra M, Infante J, Berciano J. (2002). Candidate gene association studies in sporadic Alzheimer’s disease. Dement Geriatr Cogn Disord 14:41–54.
  • Commissaris RL, Cordon JJ, Sprague S, Keiser J, Mayor GH, Rech RH. (1982). Behavioral changes in rats after chronic aluminum and parathyroid hormone administration. Neurobehav Toxicol Teratol 4:403–410.
  • Connor DJ, Harrell LE, Jope RS. (1989). Reversal of an aluminum-induced behavioral deficit by administration of deferoxamine. Behav Neurosci 103:779–783.
  • Connor DJ, Jope RS, Harrell LE. (1988). Chronic, oral aluminum administration to rats: cognition and cholinergic parameters. Pharmacol Biochem Behav 31:467–474.
  • Connor JJ, Schacklette HT. (1975). Background geochemistry of some rocks, soils, plants and vegetables in the conterminous United States. Professional Paper No. 574-F. United States Geological Survey.
  • Conway EL, O’Callaghan C, Drummer OH, Howes LG, Louis WJ. (1994). A single-dose comparison of the bioavailability of aluminium from two formulations of sucralphate in normal volunteers. Biopharm Drug Dispos 15:253–261.
  • Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. (2005). Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16:180–188.
  • Cosmetic Ingredient Review Expert Panel. (2003). Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, fuller’s earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite and zeolite. Int J Toxicol, 22, 37–102.
  • Cosnes A, Flechet ML, Revuz J. (1990). Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization. Contact Derm 23:65–67.
  • Cranmer JM, Wilkins JD, Cannon DJ, Smith L. (1986). Fetal-placental-maternal uptake of aluminum in mice following gestational exposure: effect of dose and route of administration. Neurotoxicology 7:601–608.
  • Crapper DR, Tomko GJ. (1975). Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res 97:253–264.
  • Crapper DR, Krishnan SS, Quittkat S. (1976). Aluminium, neurofibrillary degeneration and Alzheimer’s disease. Brain 99:67–80.
  • Crapper DR, Krishnan SS, Dalton AJ. (1973). Brain aluminum distribution in Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180:511–513.
  • Crapper-McLachlan DR, DeBoni U. (1980). Aluminum in human brain disease. An overview. Neurotoxicology, 1, 3–16.
  • Crapper DR, Quittkat S, Krishnan SS, Dalton AJ, De Boni U. (1980). Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol 50:19–24.
  • Crapper-McLachlan DR, Van Berkum MFA. (1986). Aluminum: A role in degenerative brain disease associated with neurofibrillary degeneration. In: Swaab DF, Fliers E, Mirmian M, Van Gool WA, Van Haaren F, eds. Progress in Brain Research. Amsterdam: Elsevier, 399–410.
  • Cruts M, Backhovens H, Wang SY, Van Gassen G, Theuns J, De Jonghe CD, Wehnert A, De Voecht J, De Winter G, Cras P. (1995). Molecular genetic analysis of familial early-onset Alzheimer’s disease linked to chromosome 14q24.3. Hum Mol Genet 4:2363–2371.
  • Dave KR, Syal AR, Katyare SS. (2002). Effect of long-term aluminum feeding on kinetics attributes of tissue cholinesterases. Brain Res Bull 58:225–233.
  • Day JP, Barker J, Evans LJ, Perks J, Seabright PJ, Ackrill P, Lilley JS, Drumm PV, Newton GW. (1991). Aluminum absorption studied by 26Al tracer. Lancet 337:1345.
  • Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM. (1992). Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer’s-disease and chronic renal-dialysis patients. Biochem J 287 (Pt 2):509–514.
  • Deering TB, Carlson GL, Malagelada JR, Duenes JA, McCall JT. (1979). Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying. Gastroenterology 77:986–990.
  • Denizeau F, Marion M, Chevalier G, Cote MG. (1985). Ultrastructural study of mineral fiber uptake by hepatocytes in vitro. Toxicol Lett 26:119–126.
  • Denizeau F, Marion M, Chevalier G, Cote MG. (1985). Absence of genotoxic effects of nonasbestos mineral fibers. Cell Biol Toxicol 1:23–32.
  • Dent CE, Winter CS. (1974). Osteomalacia due to phosphate depletion from excessive aluminium hydroxide ingestion. Br Med J 1:551–552.
  • Desjardins A, Bergeron JP, Ghezzo H, Cartier A, Malo JL. (1994). Aluminium potroom asthma confirmed by monitoring of forced expiratory volume in one second. Am J Respir Crit Care Med 150:1714–1717.
  • Deutsche Forschungsgemeinschaft. (2001). List of MAK and BAT Values, 2001. Maximum Concentrations and Biological Tolerance Values at the Workplace. Report No. 37. Weinheim: Wiley-VCH.
  • de Vernejoul MC, Marchais S, London G, Morieux C, Bielakoff J, Miravet L. (1985). Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients. Kidney Int 27:785–791.
  • De Vuyst P, Dumortier P, Rickaert F, Van de Weyer R, Lenclud C, Yernault JC. (1986). Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis 68:131–140.
  • De Vuyst P, Dumortier P, Schandené L, Estenne M, Verhest A, Yernault JC. (1987). Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 135:493–497.
  • de Wolff FA, Berend K, van der Voet GB. (2002). Subacute fatal aluminum poisoning in dialyzed patients: post-mortem toxicological findings. Forensic Sci Int 128:41–43.
  • D’Haese PC, Couttenye MM, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME. (1995). Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload. Nephrol Dial Transplant 10:1874–1884.
  • Dlugaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M. (2000). Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements. Pharmacol Toxicol 86:135–139.
  • Domingo JL, Gómez M, Bosque MA, Corbella J. (1989). Lack of teratogenicity of aluminum hydroxide in mice. Life Sci 45:243–247.
  • Domingo JL, Gomez M, Sanchez DJ, Llobet JM, Corbella J. (1993). Effect of various dietary constituents on gastrointestinal absorption of aluminum from drinking water and diet. Res Commun Chem Pathol Pharmacol 79:377–380.
  • Domingo JL, Llobet JM, Gómez M, Tomás JM, Corbella J. (1987). Nutritional and toxicological effects of short-term ingestion of aluminum by the rat. Res Commun Chem Pathol Pharmacol 56:409–419.
  • Domingo JL, Llorens J, Sanchez DJ, Gomez M, Llobet JM, Corbella J. (1996). Age-related effects of aluminum ingestion on brain aluminum accumulation and behavior in rats. Life Sci 58:1387–1395.
  • Donald JM, Golub MS, Gershwin ME, Keen CL. (1989). Neurobehavioral effects in offspring of mice given excess aluminum in diet during gestation and lactation. Neurotoxicol Teratol 11:345–351.
  • Douglas BD, Merill DT, Catlin JO. (1996). Water quality deterioration from corrosion of cement-mortar linings. J AWWA, 88, 99–107.
  • Drabek O, Mladkova L, Boruvka L, Szakova J, Nikodem A, Nemecek K. (2005). Comparison of water-soluble and exchangeable forms of Al in acid forest soils. J Inorg Biochem 99:1788–1795.
  • Driscoll CT, Letterman RD. (1988). Chemistry and fate of Al(III) in treated drinking water. J Environ Eng, 114, 21–37.
  • Drüeke TB, Jouhanneau P, Banide H, Lacour B, Yiou F, Raisbeck G. (1997). Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminium in rats. Clin Sci 92:63–67.
  • Dunea G, Mahurkar SD, Mamdani B, Smith EC. (1978). Role of aluminum in dialysis dementia. Ann Intern Med 88:502–504.
  • Dunn MA, Johnson NE, Liew MY, Ross E. (1993). Dietary aluminum chloride reduces the amount of intestinal calbindin D-28K in chicks fed low calcium or low phosphorus diets. J Nutr 123:1786–1793.
  • Dwyer CM, Kerr RE. (1993). Contact allergy to aluminium in 2 brothers. Contact Derm 29:36–38.
  • Eastwood JB, Levin GE, Pazianas M, Taylor AP, Denton J, Freemont AJ. (1990). Aluminium deposition in bone after contamination of drinking water supply. Lancet 336:462–464.
  • Ebrahim S. (1989). Aluminum and Alzheimer’s Disease. Lancet, 1, 267.
  • Ecelbarger CA, MacNeil GG, Greger JL. (1994a). Aluminum retention by aged rats fed aluminum and treated with desferrioxamine. Toxicol Lett 73:249–257.
  • Ecelbarger CA, MacNeil GG, Greger JL. (1994b). Tissue accumulation and toxic consequences in rats fed aluminum with and without citrate. J Agric Food Chem, 42, 2220–2224.
  • Edling NP. (1961). Aluminium pneumoconiosis. A roentgendiagnostic study of five cases. Acta radiol 56:170–178.
  • Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M. (2010). Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:980–982.
  • Elinder CG, Ahrengart L, Lidums V, Pettersson E, Sjögren B. (1991). Evidence of aluminium accumulation in aluminium welders. Br J Ind Med 48:735–738.
  • Elliott HL, Dryburgh F, Fell GS, Sabet S, Macdougall AI. (1978). Aluminium toxicity during regular haemodialysis. Br Med J 1:1101–1103.
  • Ellis KJ, Kelleher S, Raciti A, Savory J, Wills M. (1988). In vivo monitoring of skeletal aluminum burden in patients with renal failure. J Radioanal Nuclear Chem, 124, 85–95.
  • Ellis HA, McCarthy JH, Herrington J. (1979). Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J Clin Pathol 32:832–844.
  • El-Rahman SS. (2003). Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res 47:189–194.
  • Elward K, Larson EB. (1992). Benefits of exercise for older adults. A review of existing evidence and current recommendations for the general population. Clin Geriatr Med 8:35–50.
  • Endo-Capron S, Renier A, Janson X, Kheuang L, Jaurand MC. (1993). In vitro response of rat pleural mesothelial cells to talc samples in genotoxicity assays (sister chromatid exchanges and DNA repair). Toxicol In Vitro 7:7–14.
  • Exley C, Esiri MM. (2006). Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J Neurol Neurosurg Psychiatr 77:877–879.
  • Farina M, Lara FS, Brandão R, Jacques R, Rocha JB. (2002). Effects of aluminum sulfate on erythropoiesis in rats. Toxicol Lett 132:131–139.
  • Farina M, Rotta LN, Soares FA, Jardim F, Jacques R, Souza DO, Rocha JB. (2005). Hematological changes in rats chronically exposed to oral aluminum. Toxicology 209:29–37.
  • Faugere MC, Malluche HH. (1986). Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int 30:717–722.
  • Fawcett HA, McGibbon D, Cronin E. (1985). Persistent vaccination granuloma due to aluminum hypersensitivity. Br J Dermatol, 113, 101–102.
  • Feinroth M, Feinroth MV, Berlyne GM. (1982). Aluminum absorption in the rat everted gut sac. Miner Electrolyte Metab 8:29–35.
  • Felsenfeld AJ, Gutman RA, Llach F, Harrelson JM. (1982). Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. Am J Nephrol 2:147–154.
  • Felsenfeld AJ, Machado L, Rodriguez M. (1991). The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat. J Am Soc Nephrol 1:970–979.
  • Felsenfeld AJ, Rodriguez M, Coleman M, Ross D, Llach F. (1989). Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney Int 35:1371–1378.
  • Fernández-Martín JL, Canteros A, Alles A, Massari P, Cannata-Andía J. (2000). Aluminum exposure in chronic renal failure in iberoamerica at the end of the 1990s: overview and perspectives. Am J Med Sci 320:96–99.
  • Fernández Menéndez MJ, Fell GS, Brock JH, Cannata JB. (1991a). Aluminium uptake by intestinal cells: effect of iron status and precomplexation. Nephrol Dial Transplant 6:672–674.
  • Fernández-Menéndez, MJ, Olaizola I, Diaz López JB, Fernández Soto I, Rosa M, Cannata JB. (1991b). A double risk of aluminum hydroxide: Increased aluminum uptake and reduced iron absorption. Trace Elem Med, 8, 167–171.
  • Fink D, Walton J, Hotchkis MAC, Jacobsen GE, Lawson EM, Smith AM, Tuniz C, Wilcox D. (1994). First 26Al analyses at the ANTARES AMS Centre: Uptake via oral ingestion of 26Al in rats. Nucl Instrum Methods Phys Res Sect B, 92, 473–477.
  • Fischer T, Rystedt I. (1982). A case of contact sensitivity to aluminium. Contact Derm 8:343.
  • Flaten TP. (1991). A nation-wide survey of the chemical composition of drinking water in Norway. Sci Total Environ 102:35–73.
  • Flaten TP. (2001). Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 55:187–196.
  • Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA. (1996). Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health 48:527–541.
  • Flendrig JA, Kruis H, Das HA. (1976). Letter: Aluminum and dialysis dementia. Lancet 1:1235.
  • Forster DP, Newens AJ, Kay DW, Edwardson JA. (1995). Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health 49:253–258.
  • Fox KR. (1999). The influence of physical activity on mental well-being. Public Health Nutr 2:411–418.
  • Fraga CG, Oteiza PI, Golub MS, Gershwin ME, Keen CL. (1990). Effects of aluminum on brain lipid peroxidation. Toxicol Lett 51:213–219.
  • Freundlich M, Zilleruelo G, Abitbol C, Strauss J, Faugere MC, Malluche HH. (1985). Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet 2:527–529.
  • Freundlich M, Zilleruelo G, Faugere MC, Abitbol C, Strauss J, Malluche HH. (1986). Treatment of aluminum toxicity in infantile uremia with deferoxamine. J Pediatr 109:140–143.
  • Freundlich M, Zilleruelo G, Strauss J, Abitbol C, Malluche HH. (1990). More on aluminum toxic effects in children with uremia. J Pediatr 117:1007–1009.
  • Froment DH, Buddington B, Miller NL, Alfrey AC. (1989). Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat. J Lab Clin Med 114:237–242.
  • Frost B, Diamond MI. (2010). Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11:155–159.
  • Fulton B, Jaw S, Jeffery EH. (1989). Bioavailability of aluminum from drinking water. Fundam Appl Toxicol 12:144–150.
  • Gabelich CJ, Chen WR, Yun TI, Coffey BM, Suffet IH. (2005). The role of dissolved aluminum in silica chemistry for membrane processes. Desalination, 180, 307–319.
  • Gabrysh AF, Erying H, Cutler I. (1962). Rheological factors for attapulgite suspended in water. J Am Ceramic Soc, 45, 334–343.
  • Galceran T, Finch J, Bergfeld M, Coburn J, Martin K, Teitelbaum S, Slatopolsky E. (1987). Biological effects of aluminum on normal dogs: studies on the isolated perfused bone. Endocrinology 121:406–413.
  • Ganrot PO. (1986). Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363–441.
  • Garbossa G, Gálvez G, Pérez G, Stripeikis J, Tudino M, Nesse A. (1998). Oral aluminum administration to rats with normal renal function. 2. Body distribution. Hum Exp Toxicol 17:318–322.
  • Garbossa G, Gálvez G, Castro ME, Nesse A. (1998). Oral aluminum administration to rats wih normal renal function. 1. Impairment of erythropoiesis. Hum Exp Toxicol 17:312–317.
  • Gardner MJ, Gunn AM. (1995). Speciation and bioavailability of aluminum in drinking water. Chem Speciat Bioavail, 7, 9–16.
  • Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D. (2000). Aluminum forms in drinking water and risk of Alzheimer’s disease. Environ Res 84:234–246.
  • Geissler PW, Shulman CE, Prince RJ, Mutemi W, Mnazi C, Friis H, Lowe B. (1998). Geophagy, iron status and anaemia among pregnant women on the coast of Kenya. Trans R Soc Trop Med Hyg 92:549–553.
  • Gelfand MC, Zarate A, Knepshield JH. (1975). Geophagia. A cause of life-threatening hyperkalemia in patients with chronic renal failure. JAMA 234:738–740.
  • Gies WJ. (1911). Some objections to the use of alum baking powder. JAMA 57:816–821.
  • Gillette-Guyonnet S, Andrieu S, Nourhashemi F, de La Guéronnière V, Grandjean H, Vellas B. (2005). Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study. Am J Clin Nutr 81:897–902.
  • Golding J, Rowland A, Greenwood R, Lunt P. (1991). Aluminium sulphate in water in north Cornwall and outcome of pregnancy. BMJ 302:1175–1177.
  • Golub MS, Donald JM, Gershwin ME, Keen CL. (1989). Effects of aluminum ingestion on spontaneous motor activity of mice. Neurotoxicol Teratol 11:231–235.
  • Golub MS, Germann SL. (1998). Aluminum effects on operant performance and food motivation of mice. Neurotoxicol Teratol 20:421–427.
  • Golub MS, Germann SL. (2001). Long-term consequences of developmental exposure to aluminum in a suboptimal diet for growth and behavior of Swiss Webster mice. Neurotoxicol Teratol 23:365–372.
  • Golub MS, Germann SL, Han B, Keen CL. (2000). Lifelong feeding of a high aluminum diet to mice. Toxicology 150:107–117.
  • Golub MS, Germann SL, Keen CL. (2003). Developmental aluminum toxicity in mice can be modulated by low concentrations of minerals (Fe, Zn, P, Ca, Mg) in the diet. Biol Trace Elem Res 93:213–226.
  • Golub MS, Gershwin ME, Donald JM, Negri S, Keen CL. (1987). Maternal and developmental toxicity of chronic aluminum exposure in mice. Fundam Appl Toxicol 8:346–357.
  • Golub MS, Han B, Keen CL, Gershwin ME. (1992). Effects of dietary aluminum excess and manganese deficiency on neurobehavioral endpoints in adult mice. Toxicol Appl Pharmacol 112:154–160.
  • Golub MS, Han B, Keen CL, Gershwin ME, Tarara RP. (1995). Behavioral performance of Swiss Webster mice exposed to excess dietary aluminum during development or during development and as adults. Toxicol Appl Pharmacol 133:64–72.
  • Gomez M, Bosque MA, Domingo JL, Llobet JM, Corbella J. (1990). Evaluation of the maternal and developmental toxicity of aluminum from high doses of aluminum hydroxide in rats. Vet Hum Toxicol 32:545–548.
  • Gomez M, Domingo JL, Llobet JM. (1991). Developmental toxicity evaluation of oral aluminum in rats: influence of citrate. Neurotoxicol Teratol 13:323–328.
  • Gómez M, Sánchez DJ, Llobet JM, Corbella J, Domingo JL. (1997). The effect of age on aluminum retention in rats. Toxicology 116:1–8.
  • Gong QH, Wu Q, Huang XN, Sun AS, Shi JS. (2005). Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci 77:140–148.
  • Gonzalez JJ, Owens W, Ungaro PC, Werk EE Jr, Wentz PW. (1982). Clay ingestion: a rare cause of hypokalemia. Ann Intern Med 97:65–66.
  • Good PF, Perl DP, Bierer LM, Schmeidler J. (1992). Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol 31:286–292.
  • Goodman WG, Gilligan J, Horst R. (1984a). Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Invest 73:171–181.
  • Goodman WG, Henry DA, Horst R, Nudelman RK, Alfrey AC, Coburn JW. (1984b). Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int 25:370–375.
  • Goodman WG, O’Connor J. (1991). Aluminum alters calcium influx and efflux from bone in vitro. Kidney Int 39:602–607.
  • Gosselin RE, Smith RP, Hodge HC. (1984).Clinical toxicology of commercial products. (5th edition). Baltimore: Williams & Wilkins, II-94–95, 128.
  • Grant DJ, McMurdo ME. (1989). Aluminum and Alzheimer’s disease. Lancet, 1:268.
  • Grant W. (1997). Dietary links to Alzheimer’s disease. Alz Dis Rev, 2:42–55.
  • Greger JL. (1985). Aluminum content in the American diet. Food Technol, 39, 73–80.
  • Greger JL. (1992). Dietary and other sources of aluminum intake. In: Aluminum in biology and medicine. New York: John Wiley and Sons, 26–49.
  • Greger JL, Baier MJ. (1983a). Excretion and retention of low or moderate levels of aluminium by human subjects. Food Chem Toxicol 21:473–477.
  • Greger JL, Baier MJ. (1983b). Effect of dietary aluminum on mineral metabolism of adult males. Am J Clin Nutr 38:411–419.
  • Greger JL, Goetz W, Sullivan D. (1985a). Aluminum levels in foods cooked and stored in aluminum pans, trays and foil. J Food Prot 48:772–777.
  • Greger JL, Bula EN, Gum ET. (1985b). Mineral metabolism of rats fed moderate levels of various aluminum compounds for short periods of time. J Nutr 115:1708–1716.
  • Greger JL, Gunn ET, Bula EN. (1986). Mineral metabolism of rats fed various levels of aluminum hydroxide. Biol Trace Elem Res 9:67–77.
  • Greger JL, Powers CF. (1992). Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats. Toxicology 76:119–132.
  • Greger JL, Radzanowski GM. (1995). Tissue aluminium distribution in growing, mature and ageing rats: relationship to changes in gut, kidney and bone metabolism. Food Chem Toxicol 33:867–875.
  • Griffioen KJ, Ghribi O, Fox N, Savory J, DeWitt DA. (2004). Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. Neurotoxicology 25:859–867.
  • Griffiths DM, Hill RJ. (1983). The effects of dispersion on fibrous clays in vitro and in vivo. Ann Occup Hyg 27:405–414.
  • Griswold WR, Reznik V, Mendoza SA, Trauner D, Alfrey AC. (1983). Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatrics 71:56–58.
  • Guest WC, Silverman JM, Pokrishevsky E, O’Neill MA, Grad LI, Cashman NR. (2011). Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J Toxicol Environ Health Part A 74:1433–1459.
  • Gun RT, Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, McCusker E, Mylvaganam A. (1997). Occupational risk factors for Alzheimer disease: a case-control study. Alzheimer Dis Assoc Disord 11:21–27.
  • Haden WL, Jr. (1961). Attapulgite: properties and uses. Clays Clay Mineral 10:284–290.
  • Hahn TJ. (1989). Aluminum-related disorders of bone and mineral metabolism. Bone Miner Res 6:219–265.
  • Hall AF. (1944). Occupational contact dermatitis among aircraft workers. JAMA 125:179–185.
  • Halsted JA. (1968). Geophagia in man: its nature and nutritional effects. Am J Clin Nutr 21:1384–1393.
  • Hamdy RC. (1990). Aluminum toxicity and Alzheimer’s disease. Is there a connection? Postgrad Med 88:239–240.
  • Hantson P, Mahieu P, Gersdorff M, Sindic C, Lauwerys R. (1995). Fatal encephalopathy after otoneurosurgery procedure with an aluminum-containing biomaterial. J Toxicol Clin Toxicol 33:645–648.
  • Haram EM, Weberg R, Berstad A. (1987). Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man. Scand J Gastroenterol 22:615–618.
  • Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM. (1994). Alzheimer’s-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet 343:993–997.
  • Hazardous Substances Database (HSDB). (2011). Online database. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB
  • Heaf JG, Pødenphant J, Andersen JR. (1986). Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption. Nephron 42:210–216.
  • Hellström HO, Mjöberg B, Mallmin H, Michaëlsson K. (2005). The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls. Osteoporos Int 16:1982–1988.
  • Hemmer W, Wantke F, Focke M, Gotz M, Jarisch R. (1996). Evaluation of cutaneous hypersensitivity to aluminum by routine patch testing with A1C1(3). Contact Derm 34:217–218.
  • Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA. (1995). Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346:1387–1390.
  • Hendricks SB. (1941). Base exchange of the clay mineral monomorillonite for organic cations and its dependence upon adsorption due to Van der Waals forces. J Physical Chem 45:65–81.
  • Henry DA, Goodman WG, Nudelman RK, DiDomenico NC, Alfrey AC, Slatopolsky E, Stanley TM, Coburn JW. (1984). Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney Int 25:362–369.
  • Hercz G, Andress DL, Nebeker HG, Shinaberger JH, Sherrard DJ, Coburn JW. (1988). Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. Am J Kidney Dis 11:70–75.
  • Hewitt CD, Innes DJ, Herman MM, Savory J, Wills MR. (1992). Hematological changes after long-term aluminum administration to normal adult rabbits. Ann Clin Lab Sci 22:85–94.
  • Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. (1984). Alzheimer’s disease: a study of epidemiological aspects. Ann Neurol 15:335–341.
  • Hicks JS, Hackett DS, Sprague GL. (1987). Toxicity and aluminium concentration in bone following dietary administration of two sodium aluminium phosphate formulations in rats. Food Chem Toxicol 25:533–538.
  • Hirata-Koizumi M, Fujii S, Ono A, Hirose A, Imai T, Ogawa K, Ema M, Nishikawa A. (2011). Two-generation reproductive toxicity study of aluminium sulfate in rats. Reprod Toxicol 31:219–230.
  • Hirono N, Hashimoto M, Yasuda M, Kazui H, Mori E. (2003). Accelerated memory decline in Alzheimer’s disease with apolipoprotein epsilon4 allele. J Neuropsychiatry Clin Neurosci 15:354–358.
  • Hodsman AB, Sherrard DJ, Wong EG, Brickman AS, Lee DB, Alfrey AC, Singer FR, Norman AW, Coburn JW. (1981). Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med 94:629–637.
  • Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW. (1982). Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 54:539–546.
  • House RA. (1992). Factors affecting plasma aluminum concentrations in nonexposed workers. J Occup Med 34:1013–1017.
  • House RA. (1992). Factors affecting plasma aluminum concentrations in nonexposed workers. J Occup Med 34:1013–1017.
  • Hsu PH. (1989). Aluminum hydroxides and oxyhydroxides. In: Dixon JB, Weed SB, eds. Minerals in Soil Environments. (2nd edition). Madison: Soil Science Society of America, 331–378.
  • Huang JY, Huang CC, Lim PS, Wu MS, Leu ML. (1992). Effect of body iron stores on serum aluminum level in hemodialysis patients. Nephron 61:158–162.
  • Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC. (2005). Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65:1409–1414.
  • Hyry H, Höök-Nikanne J. (2004). Aluminium and milk allergies in an adult. Contact Derm 50:107.
  • International Agency for Research on Cancer (IARC). (1987). Attapulgite. Geneva: World Health Organization 42:159–173.
  • International Agency for Research on Cancer (IARC). (1997). IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Silica, Some Silicates, Coal Dust and para-Aramid Fibers. Geneva: World Health Organization 68:243–333.
  • International Programme on Chemical Safety (IPCS). (1997). Aluminum. Environmental Health Criteria 194. United Nations Environment Programme. 214 pp. Geneva: World Health Organization. Available at: http://www.inchem.org/documents/ehc/ehc/ehc194.htm.
  • International Programme on Chemical Safety (IPCS). 2005. Bentonite, Kaolin and Selected Clay Minerals. Environmental Health Criteria 231. United Nations Environment Programme. 122 pp. Geneva: World Health Organization. Available at: http://whqlibdoc.who.int/ehc/WHO_EHC_231.pdf.
  • Ittel TH, Buddington B, Miller NL, Alfrey AC. (1987). Enhanced gastrointestinal absorption of aluminum in uremic rats. Kidney Int 32:821–826.
  • Jablonski G, Klem KH, Danielsen CC, Mosekilde L, Gordeladze JO. (1996). Aluminium-induced bone disease in uremic rats: effect of deferoxamine. Biosci Rep 16:49–63.
  • Jacqmin H, Commenges D, Letenneur L, Barberger-Gateau P, Dartigues JF. (1994). Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol 139:48–57.
  • Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF. (1996). Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology 7:281–285.
  • Jeffery EH, Abreo K, Burgess E, Cannata J, Greger JL. (1996). Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 48:649–665.
  • Jefferson T, Rudin M, Di Pietrantonj C. (2004). Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis 4:84–90.
  • Jenkins DA, Gouldesbrough D, Smith GD, Cowie JF, Winney RJ. (1989). Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity? Nephrol Dial Transplant 4:51–56.
  • Jing Y, Wang Z, Song Y. (2004). Quantitative study of aluminum-induced changes in synaptic ultrastructure in rats. Synapse 52:292–298.
  • Johnson VJ, Kim SH, Sharma RP. (2005). Aluminum-maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. Toxicol Sci 83:329–339.
  • Joint FAO/WHO Expert Committee on Food Additives (JEFCA). 2006. Summary and Conclusions. 67th Meeting, p. 4. Food and Agriculture Organization of the United Nations and World Health Organization. WHO Food Additives Series No. 58; FAO JECFA Monograph 3. Available at: http://whqlibdoc.who.int/publications/2007/9789241660587_eng.pdf.
  • Jordan JW. (1961). Pulmonary fibrosis in a worker using an aluminum powder. Br J Ind Med 18:21–23.
  • Jouhanneau P, Raisbeck GM, Yiou F, Lacour B, Banide H, Drüeke TB. (1997). Gastrointestinal absorption, tissue retention, and urinary excretion of dietary aluminum in rats determined by using 26Al. Clin Chem 43:1023–1028.
  • Kaehny WD, Hegg AP, Alfrey AC. (1977). Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med 296:1389–1390.
  • Kalveram KJ, Rapp-Frick C, Sorck G. (1980). Misleading patch test results with aluminum Finn chambers and mercury salts. Contact Derm 6:507–508.
  • Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC. (2000). Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 20:3606–3611.
  • Kanra G, Viviani S, Yurdakök K, Ozmert E, Anemona A, Yalçin S, Demiralp O, Bilgili N, Kara A, Cengiz AB, Mutlu B, Baldini A, Marchetti E, Podda A. (2003). Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine. Pediatr Int 45:314–318.
  • Kapoor S, Naik S, Kumar R, Sharma S, Pruthi HS, Varshney S. (2005). Benign esophageal stricture following aluminium phosphide poisoning. Indian J Gastroenterol 24:261–262.
  • Karickhoff SW, Bailey GW. (1973). Optical absorption spectra of clay minerals. Clays Clay Minerals 21:59–70.
  • Karlik SJ, Eichhorn GL, Crapper McLachlan DR. (1980). Molecular interactions of aluminum with DNA. Neurotoxicol 1:83–88.
  • Kassem M, Eriksen EF, Melsen F, Mosekilde L. (1991). Antacid-induced osteomalacia: a case report with a histomorphometric analysis. J Intern Med 229:275–279.
  • Katopodis KP, Andrikos E, Pappas M, Siamopoulos KC. (2005). Effectiveness of aluminum hydroxide timing administration in relation to meals in controlling hyperphosphatemia in dialysis patients. Int J Artif Organs 28:803–807.
  • Katz AC, Frank DW, Sauerhoff MW, Zwicker GM, Freudenthal RI. (1984). A 6-month dietary toxicity study of acidic sodium aluminium phosphate in beagle dogs. Food Chem Toxicol 22:7–9.
  • Kaur A, Joshi K, Minz RW, Gill KD. (2006). Neurofilament phosphorylation and disruption: a possible mechanism of chronic aluminium toxicity in Wistar rats. Toxicology 219:1–10.
  • Kausz AT, Antonsen JE, Hercz G, Pei Y, Weiss NS, Emerson S, Sherrard DJ. (1999). Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. Am J Kidney Dis 34:688–693.
  • Kavoussi LR, Gelstein LD, Andriole GL. (1986). Encephalopathy and an elevated serum aluminum level in a patient receiving intravesical alum irrigation for severe urinary hemorrhage. J Urol 136:665–667.
  • Kaye M. (1983). Oral aluminum toxicity in a non-dialyzed patient with renal failure. Clin Nephrol 20:208–211.
  • Keenan KP, Coleman JB, McCoy CL, Hoe CM, Soper KA, Laroque P. (2000). Chronic nephropathy in ad libitum overfed Sprague-Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth. Toxicol Pathol 28:788–798.
  • Kerr DN, Ward MK, Arze RS, Ramos JM, Grekas D, Parkinson IS, Ellis HA, Owen JP, Simpson W, Dewar J. (1986). Aluminum-induced dialysis osteodystrophy: the demise of “Newcastle bone disease”? Kidney Int Suppl 18:S58–S64.
  • Khanna K. (2005). Inquiry questions long term effects on health of Camelford incident. BMJ 330:275.
  • Kim K. (2003). Perinatal exposure to aluminum alters neuronal nitric oxide synthase expression in the frontal cortex of rat offspring. Brain Res Bull 61:437–441.
  • Kim Y, Olivi L, Cheong JH, Maertens A, Bressler JP. (2007). Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells. Toxicol Appl Pharmacol 220:349–356.
  • Kim-Jung LY, Holquist C, Phillips J. (2004). FDA Safety Page. Kaopectate reformulation and upcoming label changes. Drug Topics. April 19. Available at: www.drugtopics.com
  • Kirschner EM. (1995). Production of top 50 chemicals increases substantially in 1994. Chem Eng News 74:16–22.
  • Kittrick JA. (1966). Free energy of formation of kaolinite from solubility measurements. Am Mineral 51:1457–1466.
  • Klatzo I, Wisniewski H, Streicher E. (1965). Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol 24:187–199.
  • Klein GL, Coburn JW. (1994). Total parenteral nutrition and its effects on bone metabolism. Crit Rev Clin Lab Sci 31:135–167.
  • Klein GL, Ott SM, Alfrey AC, Sherrard DJ, Hazlet TK, Miller NL, Maloney NA, Berquist WE, Ament ME, Coburn JW. (1982). Aluminum as a factor in the bone disease of long-term parenteral nutrition. Trans Assoc Am Physicians 95:155–164.
  • Klein GL, Herndon DN, Rutan TC, Barnett JR, Miller NL, Alfrey AC. (1994). Risk of aluminum accumulation in patients with burns and ways to reduce it. J Burn Care Rehabil 15:354–358.
  • Kobayashi K, Yumoto S, Nagai H, Hosoyama Y, Imamura M, Masuzawa S, Koizumi Y, Yamashita H. (1990). 26Al tracer experiment by accelerator mass spectrometry and its application to the studies for amyotrophic lateral sclerosis and Alzheimer’s disease. Proc Japan Acad Ser B 66:189–192.
  • Koch R. (1882). Die Aetiologie der Tuberculose. Berl Klin Wochenschr 19:221–230.
  • Kongerud J, Grønnesby JK, Magnus P. (1990). Respiratory symptoms and lung function of aluminum potroom workers. Scand J Work Environ Health 16:270–277.
  • Koo WW, Kaplan LA. (1988). Aluminum and bone disorders: with specific reference to aluminum contamination of infant nutrients. J Am Coll Nutr 7:199–214.
  • Koo WW, Kaplan LA, Krug-Wispe SK. (1988). Aluminum contamination of infant formulas. JPEN J Parenter Enteral Nutr 12:170–173.
  • Kopp JF, McKee GD. (1978). Methods for chemical analysis of water and wastewater. EPA/600/4-79/020. Cincinnati: U.S. EPA Environmental Monitoring and Support Laboratory.
  • Kotovirta ML, Salo OP, Visa-Tolvanen K. (1984). Contact sensitivity to aluminum. Contact Derm 11:135.
  • Kraus T, Schaller KH, Angerer J, Hilgers RD, Letzel S. (2006). Aluminosis–detection of an almost forgotten disease with HRCT. J Occup Med Toxicol 1:4.
  • Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V. (2007). Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 10 Suppl 1:1–269.
  • Kumar S. (2001). Acute toxicity of aluminium chloride, acephate, and their coexposure in male Wistar rat. Int J Toxicol 20:219–223.
  • Lahiri DK, Sambamurti K, Bennett DA. (2004). Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease. Neurobiol Aging 25:651–660.
  • Landsberg JP, McDonald B, Watt F. (1992). Absence of aluminium in neuritic plaque cores in Alzheimer’s disease. Nature 360:65–68.
  • Landsdown ABG. (1973). Production of epidermal damage in mammalian skins by some simple aluminum compounds. Br J Dermatol 89:67–76.
  • Lane RM, Farlow MR. (2005). Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer’s disease. J Lipid Res 46:949–968.
  • LaZerte BD, van Loon G, Anderson B. (1997). Aluminum in water. In: R.A. Yokel RA, Golub MS, eds. Research issues in aluminum toxicity. Washington, DC: Taylor & Francis, 17–45.
  • Leakey JE, Seng JE, Allaben WT. (2003). Body weight considerations in the B6C3F1 mouse and the use of dietary control to standardize background tumor incidence in chronic bioassays. Toxicol Appl Pharmacol 193:237–265.
  • Leblondel G, Allain P. (1980). Blood and brain aluminium concentrations in mice after intra-pertioneal injection of different aluminium compounds. Res Commun Chem Pathol Pharmacol 27:579–586.
  • Lenaz G, Strocchi P. (2009). Reactive oxygen species in the induction of toxicity. In: Ballantyne B, Marrs TC, Syversen T, eds. General and applied toxicology. (Third edition). Vol. 1. Chichester, United Kingdom: John Wiley & Sons, 367–410.
  • Léonard A, Gerber GB. (1988). Mutagenicity, carcinogenicity and teratogenicity of aluminium. Mutat Res 196:247–257.
  • Letterman RD, Driscoll CT. (1988). Survey of residual aluminum in filtered water. J Am Water Works Assoc (April), 154–158.
  • Levitt AJ, Karlinsky H. (1992). Folate, vitamin B12 and cognitive impairment in patients with Alzheimer’s disease. Acta Psychiatr Scand 86:301–305.
  • Lewis TE. (1989). Introduction. In: Lewis TE, ed. Environmental chemistry and toxicology of aluminum. Chelsea, Michigan: Lewis Publishers, Inc., 1–2.
  • Liao YH, Yu HS, Ho CK, Wu MT, Yang CY, Chen JR, Chang CC. (2004). Biological monitoring of exposures to aluminium, gallium, indium, arsenic, and antimony in optoelectronic industry workers. J Occup Environ Med 46:931–936.
  • Lieberherr M, Grosse B, Cournot-Witmer G, Thil CL, Balsan S. (1982). In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites. Calcif Tissue Int 34:280–284.
  • Lieberherr M, Grosse B, Cournot-Witmer G, Hermann-Erlee MP, Balsan S. (1987). Aluminum action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3. Kidney Int 31:736–743.
  • Lima PD, Leite DS, Vasconcellos MC, Cavalcanti BC, Santos RA, Costa-Lotufo LV, Pessoa C, Moraes MO, Burbano RR. (2007). Genotoxic effects of aluminum chloride in cultured human lymphocytes treated in different phases of cell cycle. Food Chem Toxicol 45:1154–1159.
  • Lin JL, Kou MT, Leu ML. (1996). Effect of long-term low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal insufficiency. Nephron 74:33–38.
  • Lin JL, Leu ML. (1996). Aluminium-containing agents may be toxic in predialysis chronic renal insufficiency patients. J Intern Med 240:243–248.
  • Lin JL, Yang YJ, Yang SS, Leu ML. (1997). Aluminum utensils contribute to aluminum accumulation in patients with renal disease. Am J Kidney Dis 30:653–658.
  • Lione A. (1983). The prophylactic reduction of aluminium intake. Food Chem Toxicol 21:103–109.
  • Lione A. (1984). Aluminum in foods. Nutr Rev 42:31.
  • Lione A. (1985). Aluminum intake from non-prescription drugs and sucralfate. Gen Pharmacol 16:223–228.
  • Lione A, Smith JC. (1982). The mobilization of aluminum from three brands of chewing gum. Food Chem Toxicol 20:945–946.
  • Ljunggren KG, Lidums V, Sjögren B. (1991). Blood and urine concentrations of aluminium among workers exposed to aluminium flake powders. Br J Ind Med 48:106–109.
  • Llobet JM, Colomina MT, Sirvent JJ, Domingo JL, Corbella J. (1995). Reproductive toxicology of aluminum in male mice. Fundam Appl Toxicol 25:45–51.
  • Llobet JM, Domingo JL, Gómez M, Tomás JM, Corbella J. (1987). Acute toxicity studies of aluminium compounds: antidotal efficacy of several chelating agents. Pharmacol Toxicol 60:280–283.
  • López FF, Cabrera C, Lorenzo ML, López MC. (2002). Aluminium content of drinking waters, fruit juices and soft drinks: contribution to dietary intake. Sci Total Environ 292:205–213.
  • Lotz M, Zisman E, Bartter FC. (1968). Evidence for a phosphorus-depletion syndrome in man. N Engl J Med 278:409–415.
  • Lovell MA, Ehmann WD, Markesbery WR. (1993). Laser microprobe analysis of brain aluminum in Alzheimer’s disease. Ann Neurol 33:36–42.
  • Maharaj D, Fell GS, Boyce BF, Ng JP, Smith GD, Boulton-Jones JM, Cumming RL, Davidson JF. (1987). Aluminium bone disease in patients receiving plasma exchange with contaminated albumin. Br Med J (Clin Res Ed) 295:693–696.
  • Mahieu S, del Carmen Contini M, Gonzalez M, Millen N, Elias MM. (2000). Aluminum toxicity. Hematological effects. Toxicol Lett 111:235–242.
  • Makjanic J, McDonald B, Li-Hsian Chen CP, Watt F. (1998). Absence of aluminium in neurofibrillary tangles in Alzheimer’s disease. Neurosci Lett 240:123–126.
  • Malluche HH. (2002). Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant 17 Suppl 2:21–24.
  • Malluche HH, Faugere MC, Friedler RM, Matthews C, Fanti P. (1987). Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. J Clin Invest 79:754–761.
  • Malluche HH, Meyer W, Sherman D, Massry SG. (1982). Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int 34:449–455.
  • Malluche HH, Smith AJ, Abreo K, Faugere MC. (1984). The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. N Engl J Med 311:140–144.
  • Maloney NA, Ott SM, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ. (1982). Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99:206–216.
  • Markesbery WR, Ehmann WD, Hossain TI, Alauddin M, Goodin DT. (1981). Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol 10:511–516.
  • Markesbery WR, Ehmann WD, Alauddin M, Hossain TI. (1984). Brain trace element concentrations in aging. Neurobiol Aging 5:19–28.
  • Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF. (1989). Geographical relation between Alzheimer’s disease and aluminum in drinking water. Lancet 1:59–62.
  • Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF. (1997). Aluminum concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology 8:281–286.
  • Mascolo N, Summa V, Tateo F. (2004). In vivo experimental data on the mobility of hazardous chemical elements from clay. Appl Clay Sci 21:155–163.
  • Mattson MP, Chan SL. (2001). Dysregulation of cellular calcium homeostasis in Alzheimer’s disease: bad genes and bad habits. J Mol Neurosci 17:205–224.
  • Mattson MP, Chan SL, Duan W. (2002). Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82:637–672.
  • Mayeux R, Costa R, Bell K, Merchant C, Tung MX, Jacobs D. (1999). Reduced risk of Alzheimer’s disease among individuals with low calorie intake. Neurology 59:S296–S297.
  • Mayo Clinic. (2009). Attapulgite (oral route). Available at: http://www.mayoclinic.com/health/drug-information/DR600189.
  • Mayor GH, Burnatowska-Hledin M. (1986). The metabolism of aluminum and aluminum-related encephalopathy. Semin Nephrol 6:1–4.
  • Mayor GH, Lohr TO, Sanchez TV. (1985). Aluminum metabolism and toxicity in renal failure: a review. J Environ Pathol Toxicol Oncol 6:43–50.
  • Mayura K, Abdel-Wahhab MA, McKenzie KS, Sarr AB, Edwards JF, Naguib K, Phillips TD. (1998). Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: potential for hidden risks. Toxicol Sci 41:175–182.
  • Mazzaferro S, Perruzza I, Costantini S, Pasquali M, Onorato L, Sardella D, Giordano R, Ciaralli L, Ballanti P, Bonucci E, Cinotti GA, Coen G. (1997). Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients. Nephrol Dial Transplant 12:2679–2682.
  • McDermott JR, Smith AI, Iqbal K, Wisniewski HM. (1977). Aluminium and Alzheimer’s disease. Lancet 2:710–711.
  • McDermott JR, Smith AI, Iqbal K, Wisniewski HM. (1979). Brain aluminum in aging and Alzheimer disease. Neurology 29:809–814.
  • McDermott JR, Smith AI, Ward MK, Parkinson IS, Kerr DN. (1978). Brain-aluminium concentration in dialysis encephalopathy. Lancet 1:901–904.
  • McGregor SJ, Naves ML, Oria R, Vass JK, Brock JH. (1990). Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells. Biochem J 272:377–382.
  • McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL. (1996). Risk for neuropathologically confirmed Alzheimer’s disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46:401–405.
  • McLean SA, Allen BL, Craig JR. (1972). The occurrence of sepiolite and attapulgite on the southern high plains. Clays Clay Minerals 20:143–149.
  • McMillan TM, Dunn G, Colwill SJ. (1993a). Psychological testing on schoolchildren before and after pollution of drinking water in North Cornwall. J Child Psychol Psychiatry 34:1449–1459.
  • McMillan TM, Freemont AJ, Herxheimer A, Denton J, Taylor AP, Pazianas M, Cummin AR, Eastwood JB. (1993b). Camelford water poisoning accident: serial neuropsychological assessments and further observations on bone aluminium. Hum Exp Toxicol 12:37–42.
  • Mengel CE, Carter WA, Horton ES. (1964). Geophagia with iron deficiency and hypokalemia. Cachexia africana. Arch Intern Med 114:470–474.
  • Merchant JA. (1990). Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease. Environ Health Perspect 88:287–293.
  • Meredith PA, Moore MR, Goldberg A. (1977). Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme 22:22–27.
  • Meunier PJ. (2004). Postmenopausal osteoporosis and strontium ranelate. N Engl J Med 350:2001–2003.
  • Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M. (2006). Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784.
  • Miller JL, Hubbard CM, Litman BJ, Macdonald TL. (1989). Inhibition of transducin activation and guanosine triphosphatase activity by aluminum ion. J Biol Chem 264:243–250.
  • Miller RG, Kopfler FC, Kelty KC, Stober JA, Ulmer NS. (1984). The occurrence of aluminum in drinking water. J AWWA, 84–91.
  • Milliner DS, Nebeker HG, Ott SM, Andress DL, Sherrard DJ, Alfrey AC, Slatopolsky EA, Coburn JW. (1984). Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med 101:775–779.
  • Minnich V, Okçuoglu A, Tarcon Y, Arcasoy A, Cin S, Yörükoglu O, Renda F, Demirag B. (1968). Pica in Turkey. II. Effect of clay upon iron absorption. Am J Clin Nutr 21:78–86.
  • Misawa T, Shigeta S. (1993). Effects of prenatal aluminum treatment on development and behavior in the rat. J Toxicol Sci 18:43–48.
  • Miu AC, Andreescu CE, Vasiu R, Olteanu AI. (2003). A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. Int J Neurosci 113:1197–1211.
  • Molitoris BA, Froment DH, Mackenzie TA, Huffer WH, Alfrey AC. (1989). Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int 36:949–953.
  • Molloy DW, Standish TI, Nieboer E, Turnbull JD, Smith SD, Dubois S. (2007). Effects of acute exposure to aluminum on cognition in humans. J Toxicol Environ Health Part A 70:2011–2019.
  • Moon J, Davison A, Bandy B. (1992). Vitamin D and aluminum absorption. CMAJ 147:1308, 1313.
  • Moore JG, Coburn JW, Sanders MC, McSorley DJ, Sirgo MA. (1995). Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers. Pharmacotherapy 15:742–746.
  • Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA. (2000). Absorption of aluminium-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 11:66–69.
  • Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA. (2004). Absorption of aluminium-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 11:66–69.
  • Moreno A, Domínguez C, Ballabriga A. (1994). Aluminum in the neonate related to parenteral nutrition. Acta Paediatr 83:25–29.
  • Morrissey J, Rothstein M, Mayor G, Slatopolsky E. (1983). Suppression of parathyroid hormone secretion by aluminum. Kidney Int 23:699–704.
  • Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT. (1996). A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer’s disease and strongly with the epsilon 4 allele. Neurology 47:196–201.
  • Muller G, Bernuzzi V, Desor D, Hutin MF, Burnel D, Lehr PR. (1990). Developmental alterations in offspring of female rats orally intoxicated by aluminum lactate at different gestation periods. Teratology 42:253–261.
  • Murayama H, Shin RW, Higuchi J, Shibuya S, Muramoto T, Kitamoto T. (1999). Interaction of aluminum with PHFtau in Alzheimer’s disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method. Am J Pathol 155:877–885.
  • Murphy CP, Cox RL, Harden EA, Stevens DA, Heye MM, Herzig RH. (1992). Encephalopathy and seizures induced by intravesical alum irrigations. Bone Marrow Transplant 10:383–385.
  • Mussi I, Calzaferri G, Buratti M, Alessio L. (1984). Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects. Int Arch Occup Environ Health 54:155–161.
  • Nagy E, Jobst K. (1994). The kinetics of aluminium-containing antacid absorption in man. Eur J Clin Chem Clin Biochem 32:119–121.
  • Nagy S, Nikdel S. (1986). Tin, iron and aluminum contents of commercially canned single-strength grapefruit juice stored at varying temperatures. J Agric Food Chem 34:588–593.
  • Nathan E, Pedersen SE. (1980). Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally. Acta Paediatr Scand 69:793–796.
  • National Research Council (NRC). (1977). Drinking Water and Health. Volume I. Washington, DC: National Academy Press, 136–138.
  • National Research Council (NRC). (2000). Watershed management for potable water supply. Assessing the New York city strategy. Washington, DC: National Academy Press.
  • Nayak P. (2002). Aluminum: impacts and disease. Environ Res 89:101–115.
  • Netter P, Kessler M, Burnel D, Hutin MF, Delones S, Benoit J, Gaucher A. (1984). Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds. J Rheumatol 11:66–70.
  • Netter P, Kessler M, Gaucher A, Gillet P, Delons S, Burnel D, Benoit J, Got C. (1988). Aluminium and dialysis arthropathy. Lancet 1:886–887.
  • Nieboer E, Gibson BL, Oxman AD, Kramer JR. (1995). Health effects of aluminum: A critical review with emphasis on aluminum in drinking water. Environ Rev 3:29–81.
  • Nolan RP, Langer AM, Herson GB. (1991). Characterisation of palygorskite specimens from different geological locales for health hazard evaluation. Br J Ind Med 48:463–475.
  • Nordal KP, Dahl E, Halse J, Aksnes L, Thomassen Y, Flatmark A. (1992). Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study. J Clin Endocrinol Metab 74:1140–1145.
  • Norris KC, Crooks PW, Nebeker HG, Hercz G, Milliner DS, Gerszi K, Slatopolsky E, Andress DL, Sherrard DJ, Coburn JW. (1985). Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and “epidemic” forms of the syndrome. Am J Kidney Dis 6:342–347.
  • Norris K, Goodman W, Howard N, Nugent M, Coburn J. (1986). Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to use of deferoxamine. Semin Nephrol 6:S27–S34.
  • O’Driscoll JB, Beck MB, Kesseler ME, Ford G. (1991). Contact sensitivity to aluminium acetate eardrops. Contact Derm 24:156–157.
  • Ohman LO, Martin RB. (1994). Citrate as the main small molecule binding Al3+ in serum. Clin Chem 40:598–601.
  • Ohyashiki T, Satoh E, Okada M, Takadera T, Sahara M. (2002). Nerve growth factor protects against aluminum-mediated cell death. Toxicology 176:195–207.
  • Okcuoglu A, Arcasoy A, Minnich V, Tarcon Y, Cin S, Yörükoglu O, Demirag B, Renda F. (1966). Pica in Turkey. 1. The incidence and association with anemia. Am J Clin Nutr 19:125–131.
  • Ondreicka R, Ginter E, Kortus J. (1966). Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism. Br J Ind Med 23:305–312.
  • Oneda S, Takasaki T, Kuriwaki K, Ohi Y, Umekita Y, Hatanaka S, Fujiyoshi T, Yoshida A, Yoshida H. (1994). Chronic toxicity and tumorigenicity study of aluminum potassium sulfate in B6C3F1 mice. In Vivo 8:271–278.
  • Orme J, Ohanian EV. (1990). Assessing health risks of aluminum. Environ Geochem Health 12:55–58.
  • Osol A, Farrar GE, Jr. (1955). United States Dispensatory and Physicians’ Pharmacology. 25th ed. Philadelphia: JB Lippincott Co., 646–647
  • Oteiza PI, Keen CL, Han B, Golub MS. (1993). Aluminum accumulation and neurotoxicity in Swiss-Webster mice after long-term dietary exposure to aluminum and citrate. Metab Clin Exp 42:1296–1300.
  • Ott SM, Feist E, Andress DL, Liu CC, Sherrard DJ, Alfrey AC, Slatopolsky E, Howard GA. (1987). Development and reversibility of aluminum-induced bone lesion in the rat. J Lab Clin Med 109:40–47.
  • Ott SM, Maloney NA, Alfrey AC, Coburn JW, Sherrard DJ. (1981). Prevalence of aluminum (Al) in bone from uremic patients. Kidney Int 21:138.
  • Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ. (1982). The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307:709–713.
  • Owen LM, Crews HM, Bishop NJ, Massey RC. (1994). Aluminium uptake from some foods by guinea pigs and the characterization of aluminium in in vivo intestinal digesta by SEC-ICP-MS. Food Chem Toxicol 32:697–705.
  • Owen PJ, Miles DP. (1995). A review of hospital discharge rates in a population around Camelford in North Cornwall up to the fifth anniversary of an episode of aluminium sulphate absorption. J Public Health Med 17:200–204.
  • Owen PJ, Miles DP, Draper GJ, Vincent TJ. (2002). Retrospective study of mortality after a water pollution incident at Lowermoor in north Cornwall. BMJ 324:1189.
  • Parfitt AM. (1983). The physiological and clinical significance of bone histomorphometric data. In: Becker RR, ed. Bone Histomorphometry: Techniques and Interpretation. Boca Raton: CRC Press, 183–185.
  • Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN. (1979). Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406–409.
  • Paternain JL, Domingo JL, Llobet JM, Corbella J. (1988). Embryotoxic and teratogenic effects of aluminum nitrate in rats upon oral administration. Teratology 38:253–257.
  • Patterson EC, Staszak DJ. (1977). Effects of geophagia (kaolin ingestion) on the maternal blood and embryonic development in the pregnant rat. J Nutr 107:2020–2025.
  • Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, Saiphoo C, Fenton S. (1992). Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int 41:1374–1382.
  • Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D. (1995). Risk factors for renal osteodystrophy: a multivariant analysis. J Bone Miner Res 10:149–156.
  • Perez-Tur J, Froelich S, Prihar G, Crook R, Baker M, Duff K, Wragg M, Busfield F, Lendon C, Clark RF. (1995). A mutation in Alzheimer’s disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7:297–301.
  • Perl DP, Brody AR. (1980). Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208:297–299.
  • Perl DP, Good PF. (1987). The association of aluminum Alzheimer’s disease, and neurofibrillary tangles. J Neural Transm Suppl 24:205–211.
  • Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs CJ. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217:1053–1055.
  • Pettersen JC, Hackett DS, Zwicker GM, Sprague GL. (1990). Twenty-six week toxicity study with KASAL® (basic sodium aluminum phosphate) in beagle dogs. Environ Geochem Health 12:121–123.
  • Phillips TD. (1999). Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicol Sci 52:118–126.
  • Phillips TD, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah NA, Ofori-Adjei D, Jolly P, Johnson N, Taylor J, Marroquin-Cardona A, Xu L, Tang L, Wang JS. (2008). Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:134–145.
  • Pierides AM, Edwards WG Jr, Cullum UX Jr, McCall JT, Ellis HA. (1980). Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int 18:115–124.
  • Pivnick EK, Kerr NC, Kaufman RA, Jones DP, Chesney RW. (1995). Rickets secondary to phosphate depletion. A sequela of antacid use in infancy. Clin Pediatr (Phila) 34:73–78.
  • Polinsky MS, Gruskin AB. (1984). Aluminum toxicity in children with chronic renal failure. J Pediatr 105:758–761.
  • Polvikoski T, Sulkava R, Rastas S, Sutela A, Niinistö L, Notkola IL, Verkkoniemi A, Viramo P, Juva K, Haltia M. (2006). Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study. Neuroepidemiology 26:76–82.
  • Powell JJ, Greenfield SM, Thompson RP, Cargnello JA, Kendall MD, Landsberg JP, Watt F, Delves HT, House I. (1995). Assessment of toxic metal exposure following the Camelford water pollution incident: evidence of acute mobilization of lead into drinking water. Analyst 120:793–798.
  • Powell JJ, Thompson RP. (1990). Aluminium deposition in bone after contamination of drinking water supply. Lancet 336:888.
  • Priest ND. (2004). The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update. J Environ Monit 6:375–403.
  • Priest ND, Talbot RJ, Austin JG, Day JP, King SJ, Fifield K, Cresswell RG. (1996). The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers. Biometals 9:221–228.
  • Priest ND, Talbot RJ, Newton D, Day JP, King SJ, Fifield LK. (1998). Uptake by man of aluminium in a public water supply. Hum Exp Toxicol 17:296–301.
  • Provan SD, Yokel RA. (1988). Influence of calcium on aluminum accumulation by the rat jejunal slice. Res Commun Chem Pathol Pharmacol 59:79–92.
  • Quarles LD. (1990). Attenuated bone aluminum deposition in nonuremic beagles with reduced bone remodeling. Am J Physiol 258:E576–E581.
  • Quarles LD. (1991). Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233–239.
  • Quarles LD, Dennis VW, Gitelman HJ, Harrelson JM, Drezner MK. (1985). Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs. J Clin Invest 75:1441–1447.
  • Quarles LD, Gitelman HJ, Drezner MK. (1988). Induction of de novo bone formation in the beagle. A novel effect of aluminum. J Clin Invest 81:1056–1066.
  • Quarles LD, Gitelman HJ, Drezner MK. (1989). Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644–1650.
  • Rai D, Kittrick JA. (1989). Mineral equilibria in the soil system. In: Dixon JB, Weed SB, eds. Minerals in Soil Environments. (second edition). Vol. 1. Madison: Soil Science Society of America, 161–198.
  • Rainville AJ. (1998). Pica practices of pregnant women are associated with lower maternal hemoglobin level at delivery. J Am Diet Assoc 98:293–296.
  • Rauch H, Fleischer F, Böhrer H, Jürs G, Wilhelm M, Krier C. (1989). Serum aluminium levels of intensive care patients treated with two different antacids for prevention of stress ulceration. Intensive Care Med 15:84–86.
  • Rao VS, Cupples A, van Duijn CM, Kurz A, Green RC, Chui H, Duara R, Auerbach SA, Volicer L, Wells J, van Broeckhoven C, Growdon JH, Haines JL, Farrer LA. (1996). Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am J Hum Genet 59:664–675.
  • Recker RR, Blotcky AJ, Leffler JA, Rack EP. (1977). Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med 90:810–815.
  • Reiber S, Kukull W, Standish-Lee P. (1995). Drinking water aluminum and bioavailability. J Am Water Works Assoc 87:86–100.
  • Reid RM. (1992). Cultural and medical perspectives on geophagia. Med Anthropol 13:337–351.
  • Reinke CM, Breitkreutz J, Leuenberger H. (2003). Aluminium in over-the-counter drugs: risks outweigh benefits? Drug Saf 26:1011–1025.
  • Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B, Barcikowska M. (2003). Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer’s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16:64–70.
  • Reusche E. (1997). Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy. Acta Neuropathol 94:612–616.
  • Reusche E, Seydel U. (1993). Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis. Acta Neuropathol 86:249–258.
  • Reusche E, Pilz P, Oberascher G, Lindner B, Egensperger R, Gloeckner K, Trinka E, Iglseder B. (2001a). Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report. Hum Pathol 32:1136–1140.
  • Reusche E, Koch V, Lindner B, Harrison AP, Friedrich HJ. (2001b). Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis. Acta Neuropathol 101:211–216.
  • Rivera ER, Armstrong WD, Clawson AJ, Linnerud AC. (1978). Effect of dietary oats and kaolin on performance and incidence of diarrhea in weanling pigs. J Anim Sci 46:1685–1693.
  • Robertson JA, Felsenfeld AJ, Haygood CC, Wilson P, Clarke C, Llach F. (1983). Animal model of aluminum-induced osteomalacia: role of chronic renal failure. Kidney Int 23:327–335.
  • Rodella LF, Ricci F, Borsani E, Rezzani R, Stacchiotti A, Mariani C, Bianchi R. (2006). Exposure to aluminium changes the NADPH-diaphorase/NPY pattern in the rat cerebral cortex. Arch Histol Cytol 69:13–21.
  • Rodella L, Rezzani R, Lanzi R, Bianchi R. (2001). Chronic exposure to aluminium decreases NADPH-diaphorase positive neurons in the rat cerebral cortex. Brain Res 889:229–233.
  • Rödelsperger K, Brückel B, Manke J, Woitowitz HJ, Pott F. (1987). Potential health risks from the use of fibrous mineral absorption granulates. Br J Ind Med 44:337–343.
  • Rodriguez M, Felsenfeld AJ, Llach F. (1989). The evolution of osteomalacia in the rat with acute aluminum toxicity. J Bone Miner Res 4:687–696.
  • Rodriguez M, Felsenfeld AJ, Llach F. (1990). Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59–67.
  • Rogers MA, Simon DG. (1999). A preliminary study of dietary aluminium intake and risk of Alzheimer’s disease. Age Ageing 28:205–209.
  • Roider G, Drash G. (1999). Concentrations of aluminum in human tissues − investigations on an occupationally non-exposed population in Southern Germany (Bavaria). Trace Elem Electrolytes 16:77–86.
  • Roig JL, Fuentes S, Teresa Colomina M, Vicens P, Domingo JL. (2006). Aluminum, restraint stress and aging: behavioral effects in rats after 1 and 2 years of aluminum exposure. Toxicology 218:112–124.
  • Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. (2000). Relation between aluminum concentrations in drinking water and Alzheimer’s disease: an 8-year follow-up study. Am J Epidemiol 152:59–66.
  • Rondeau V, Jacqmin-Gadda H, Commenges D, Dartigues JF. (2001). Aluminum in drinking water and cognitive decline in elderly subjects: the Paquid cohort. Am J Epidemiol 154:288–290.
  • Rondeau V, Iron A, Letenneur L, Commenges D, Duchêne F, Arveiler B, Dartigues JF. (2006). Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer’s disease. Eur J Neurol 13:1022–1025.
  • Rosborg I, Nihlgård B, Gerhardsson L, Gernersson ML, Ohlin R, Olsson T. (2005). Concentrations of inorganic elements in bottled waters on the Swedish market. Environ Geochem Health 27:217–227.
  • Rosborg I, Nihlgård B, Gerhardsson L, Sverdrup H. (2006). Concentrations of inorganic elements in 20 municipal waters in Sweden before and after treatment–links to human health. Environ Geochem Health 28:215–229.
  • Roselle HA. (1970). Association of laundry starch and clay ingestion with anemia in New York City. Arch Intern Med 125:57–61.
  • Rosenlöf K, Fyhrquist F, Tenhunen R. (1990). Erythropoietin, aluminium, and anaemia in patients on haemodialysis. Lancet 335:247–249.
  • Rossbach B, Buchta M, Csanády GA, Filser JG, Hilla W, Windorfer K, Stork J, Zschiesche W, Gefeller O, Pfahlberg A, Schaller KH, Egerer E, Pinzón LC, Letzel S. (2006). Biological monitoring of welders exposed to aluminium. Toxicol Lett 162:239–245.
  • Rowland A, Grainger R, Smith RS, Hicks N, Hughes A. (1990). Water contamination in North Cornwall: a retrospective cohort study into the acute and short-term effects of the aluminum sulphate incident in July 1988. J R Soc Health 110:166–172.
  • Roy AK, Talukder G, Sharma A. (1991). Similar effects in vivo of two aluminum salts on the liver, kidney, bone, and brain of Rattus norvegicus. Bull Environ Contam Toxicol 47:288–295.
  • Rozman K. (1988). Disposition of xenobiotics: species differences. Toxicol Pathol 16:123–129.
  • Rusch GM. (1984). A review of the toxicity of aluminum and its salts. 40 pp. Department of Toxicology. Morristown, New Jersey: Allied Corporation.
  • Russo LS, Beale G, Sandroni S, Ballinger WE. (1992). Aluminium intoxication in undialysed adults with chronic renal failure. J Neurol Neurosurg Psychiatr 55:697–700.
  • Salib E, Hillier V. (1996). A case-control study of Alzheimer’s disease and aluminium occupation. Br J Psychiatry 168:244–249.
  • Salina P, Falkeborn Y, Frech W, Cedergren A. (1984). Aluminum concentrations in the brain and bone of rats fed citric acid, aluminum citrate and aluminum hydroxide. Food Chem Toxicol 22:391–397.
  • Salusky IB, Coburn JW, Paunier L, Sherrard DJ, Fine RN. (1984). Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. J Pediatr 105:717–720.
  • Salusky IB, Coburn JW, Nelson P, Goodman WG. (1990). Prospective evaluation of aluminum loading from formula in infants with uremia. J Pediatr 116:726–729.
  • Salusky IB, Foley J, Nelson P, Goodman WG. (1991). Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324:527–531.
  • Sárszegi Z, Nagy J, Jobst K. (1997). The kinetics of initial gastrointestinal absorption of an aluminium-containing antacid (Tisacid) in patients with various stages of chronic renal insufficiency. Nephrol Dial Transplant 12:372–373.
  • Sass JB, Ang LC, Juurlink BH. (1993). Aluminum pretreatment impairs the ability of astrocytes to protect neurons from glutamate mediated toxicity. Brain Res 621:207–214.
  • Savory J. (1994). Iatrogenic aluminum poisoning. Clin Chem 40:1477–1478.
  • Savory J, Exley C, Forbes WF, Huang Y, Joshi JG, Kruck T, McLachlan DR, Wakayama I. (1996). Can the controversy of the role of aluminum in Alzheimer’s disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J Toxicol Environ Health 48:615–635.
  • Savory J, Rao JK, Huang Y, Letada PR, Herman MM. (1999). Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. Neurotoxicology 20:805–817.
  • Say B, Ozsoylu S, Berkel I. (1969). Geophagia associated with iron-deficiency anemia, hepatosplenomegaly, hypogonadism and dwarfism. A syndrome probably associated with zinc deficiency. Clin Pediatr (Phila) 8:661–668.
  • Schenck RU, Bjorksten J, Yeager L. (1989). Composition and consequences of aluminum in water, beverages and other ingestibles. In: Lewis TE, ed. Environmental chemistry and toxicology of aluminum. Chelsea, Michigan: Lewis Publishers, Inc., 247–269.
  • Scholtz CL, Swash M, Gray A, Kogeorgos J, Marsh F. (1987). Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. Clin Neuropathol 6:93–97.
  • Schönholzer KW, Sutton RA, Walker VR, Sossi V, Schulzer M, Orvig C, Venczel E, Johnson RR, Vetterli D, Dittrich-Hannen B, Kubik P, Suter M. (1997). Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry. Clin Sci 92:379–383.
  • Schroeder HA, Mitchener M. (1975). Life-term effects of mercury, methyl mercury, and nine other trace metals on mice. J Nutr 105:452–458.
  • Schulz W, Deuber HJ, Popperl G. (1984). On the differential diagnosis and therapy of dialysis osteomalacia under special consideration to a therapy with oral phosphate binders. Trace Elem Med 1:120–127.
  • Schupf N, Silverman W, Zigman WB, Moreta RC, Wisnewski HM. (1989). Aluminum and Alzheimer’s disease. Lancet 1:267.
  • ScienceLab.com. (2011). Material Safety Data Sheet. Kaolin MSDS. Sciencelab.com, Inc., 14025 Smith Road, Houston, Texas. Available at: http://sciencelab.com/xMSDS-Kaolin-9927200.
  • Sedman AB, Alfrey AC, Miller NL, Goodman WG. (1987). Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. J Clin Invest 79:86–92.
  • Sedman AB, Miller NL, Warady BA, Lum GM, Alfrey AC. (1984a). Aluminum loading in children with chronic renal failure. Kidney Int 26:201–204.
  • Sedman AB, Wilkening GN, Warady BA, Lum GM, Alfrey AC. (1984b). Encephalopathy in childhood secondary to aluminum toxicity. J Pediatr 105:836–838.
  • Sedman AB, Klein GL, Merritt RJ, Miller NL, Weber KO, Gill WL, Anand H, Alfrey AC. (1985). Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med 312:1337–1343.
  • Seshadri S, Drachman DA, Lippa CF. (1995). Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer’s disease. What physicians know, and what they should know. Arch Neurol 52:1074–1079.
  • Severance HW Jr, Holt T, Patrone NA, Chapman L. (1988). Profound muscle weakness and hypokalemia due to clay ingestion. South Med J 81:272–274.
  • Shah NR, Oberkircher OR, Lobel JS. (1990). Aluminum-induced microcytosis in a child with moderate renal insufficiency. Am J Pediatr Hematol Oncol 12:77–79.
  • Sharma P, Mishra KP. (2006). Aluminum-induced maternal and developmental toxicity and oxidative stress in rat brain: response to combined administration of Tiron and glutathione. Reprod Toxicol 21:313–321.
  • Sharp CA, Perks J, Worsfold M, Day JP, Davie MW. (1993). Plasma aluminium in a reference population: the effects of antacid consumption and its influence on biochemical indices of bone formation. Eur J Clin Invest 23:554–560.
  • Sharp FR, Vobe RA, Williams DR. (1995). Chemical speciation of aluminum in beers. Chem Speciat Bioavail, 7, 49–55.
  • Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB, Yanuzzi L, Fuchs W, Lebwohl M. (2005). Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol 53:610–615.
  • Sherrard DJ. (1986). Aluminum and renal osteodystrophy. Semin Nephrol 6:5–11.
  • Shi-Lei S, Guang-Yu MA, Bachelor LH, Bachelor ZY, Dong HM, Xu XH. (2005). Effect of naloxone on aluminum-induced learning and memory impairment in rats. Neurol India 53:79–82.
  • Shirabe T, Irie K, Uchida M. (2002). Autopsy case of aluminum encephalopathy. Neuropathology 22:206–210.
  • Shorr E, Carter AC. (1950). Aluminum gels in the management of renal phosphatic calculi. J Am Med Assoc 144:1549–1556.
  • Silva VS, Cordeiro JM, Matos MJ, Oliveira CR, Gonçalves PP. (2002). Aluminum accumulation and membrane fluidity alteration in synaptosomes isolated from rat brain cortex following aluminum ingestion: effect of cholesterol. Neurosci Res 44:181–193.
  • Silva VS, Duarte AI, Rego AC, Oliveira CR, Gonçalves PP. (2005). Effect of chronic exposure to aluminium on isoform expression and activity of rat (Na+/K+)ATPase. Toxicol Sci 88:485–494.
  • Silva VS, Nunes MA, Cordeiro JM, Calejo AI, Santos S, Neves P, Sykes A, Morgado F, Dunant Y, Gonçalves PP. (2007). Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase. Toxicology 236:158–177.
  • Silwood CJ, Grootveld M. (2005). Evaluation of the speciation status of aluminium(III) ions in isolated osteoarthritic knee-joint synovial fluid. Biochim Biophys Acta 1725:327–339.
  • Singh S, Singh D, Wig N, Jit I, Sharma BK. (1996). Aluminum phosphide ingestion–a clinico-pathologic study. J Toxicol Clin Toxicol 34:703–706.
  • Sjögren B, Elinder CG, Lidums V, Chang G. (1988). Uptake and urinary excretion of aluminum among welders. Int Arch Occup Environ Health 60:77–79.
  • Skalsky HL, Carchman RA. (1983). Aluminum homeostasis in man. J Am Coll Toxicol, 2, 405–423.
  • Slanina P, Falkeborn Y, Frech W, Cedergren A. (1984). Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food Chem Toxicol 22:391–397.
  • Slanina P, Frech W, Bernhardson A, Cedergren A, Mattsson P. (1985). Influence of dietary factors on aluminium absorption and retention in the brain and bone of rats. Acta Pharmacol Toxicol (Copenh) 56:331–336.
  • Smith AJ, Faugère MC, Abreo K, Fanti P, Julian B, Malluche HH. (1986). Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 6:275–283.
  • Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. (1996). Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun Study. JAMA 275:528–532.
  • Somova LI, Kahn MS. (1996). Aluminum intoxication in rats. II. Chronic toxicity: Effects on aluminum balance, aluminum plasma and tissue levels and haematology. SA J Food Sci Nutr, 8, 102–105.
  • Somova LI, Missankov A, Khan MS. (1997). Chronic aluminum intoxication in rats: dose-dependent morphological changes. Methods Find Exp Clin Pharmacol 19:599–604.
  • Sorenson JR, Campbell IR, Tepper LB, Lingg RD. (1974). Aluminum in the environment and human health. Environ Health Perspect 8:3–95.
  • Sorensen KC, Stucki JW, Warner RE, Wagner ED, Plewa MJ. (2005). Modulation of the genotoxicity of pesticides reacted with redox-modified smectite clay. Environ Mol Mutagen 46:174–181.
  • Søyseth V, Boe J, Kongerud J. (1997). Relation between decline in FEV1 and exposure to dust and tobacco smoke in aluminium potroom workers. Occup Environ Med 54:27–31.
  • Søyseth V, Kongerud J, Kjuus H, Boe J. (1994). Bronchial responsiveness and decline in FEV1 in aluminium potroom workers. Eur Respir J 7:888–894.
  • Speizer FE. (1983). Environmental lung diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin J, Fauci AS, Kasper DL, eds. Harrison’s Principles of Internal Medicine. (13th edition). New York: McGraw-Hill Book Company, 1176–1183.
  • Spencer H, Kramer L, Norris C, Osis D. (1982). Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism. Am J Clin Nutr 36:32–40.
  • Spencer H, Kramer L, Osis D, Wiatrowski E. (1985). Effects of aluminum hydroxide on fluoride and calcium metabolism. J Environ Pathol Toxicol Oncol 6:33–41.
  • Stables GI, Forsyth A, Lever RS. (1996). Patch testing in children. Contact Derm 34:341–344.
  • Stanek EJ 3rd, Calabrese EJ, Barnes R, Pekow P. (1997). Soil ingestion in adults–results of a second pilot study. Ecotoxicol Environ Saf 36:249–257.
  • Stauber JL, Florence TM, Davies CM, Adam MS, Buchanan SJ. (1999). Bioavailability of Al in alum-treated drinking water. J Am Water Works Assoc, 91, 84–93.
  • Steinhausen C, Kislinger G, Winklhofer C, Beck E, Hohl C, Nolte E, Ittel TH, Alvarez-Brückmann MJ. (2004). Investigation of the aluminium biokinetics in humans: a 26Al tracer study. Food Chem Toxicol 42:363–371.
  • Strong MJ, Garruto RM, Joshi JG, Mundy WR, Shafer TJ. (1996). Can the mechanisms of aluminum neurotoxicity be integrated into a unified scheme? J Toxicol Environ Health 48:599–613.
  • Suárez-Fernández MB, Soldado AB, Sanz-Medel A, Vega JA, Novelli A, Fernández-Sánchez MT. (1999). Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res 835:125–136.
  • Sugawara C, Sugawara N, Kiyosawa H, Miyake H. (1988). Decrease of serum triglyceride in normal rat fed with 2000 ppm aluminum diet for 67 days. II. Feeding young and adult rats a sucrose diet with addition of aluminum hydroxide and aluminum potassium sulfate. Fundam Appl Toxicol 10:616–623.
  • Sugawara C, Sugawara N, Kiyosawa H, Miyake H. (1988). Decrease of serum triglyceride in normal rats fed with 2000 ppm aluminum diet for 67 days. I. Feeding young rats sucrose, lactose, milk, casein or soy-protein diets with addition of aluminum chloride. Fundam Appl Toxicol 10:607–615.
  • Sutherland JE, Greger JL. (1998a). Kinetics of aluminum disposition after ingestion of low to moderate pharmacological doses of aluminum. Toxicology 126:115–125.
  • Sutherland JE, Greger JL. (1998b). Effect of the size of an oral dose of aluminium on the relative importance of biliary v. urinary aluminium excretion in conscious rats. Food Chem Toxicol 36:505–512.
  • Swegert CV, Dave KR, Katyare SS. (1999). Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech Ageing Dev 112:27–42.
  • Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R. (2001). Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56:49–56.
  • Taylor E, Devakumar M. (1989). Aluminum and Alzheimer’s disease. Lancet, 1, 267.
  • Taylor GA, Newens AJ, Edwardson JA, Kay DW, Forster DP. (1995). Alzheimer’s disease and the relationship between silicon and aluminium in water supplies in northern England. J Epidemiol Community Health 49:323–324.
  • Taylor GA, Moore PB, Ferrier IN, Tyrer SP, Edwardson JA. (1998). Gastrointestinal absorption of aluminium and citrate in man. J Inorg Biochem 69:165–169.
  • Tennakone K, Wickramanayake S. (1987). Aluminium leaching from cooking utensils. Nature 325:202.
  • Terry RD, Pena C. (1965). Experimental production of neurofibrillary degeneration 2. electron microscopy, phosphatase histochemistry and electron probe analysis. J Neuropathol Exp Neurol 24:200–210.
  • Thériault G, Tremblay C, Cordier S, Gingras S. (1984). Bladder cancer in the aluminium industry. Lancet 1:947–950.
  • Thériault GP, Tremblay CG, Armstrong BG. (1990). Bladder cancer screening among primary aluminum production workers in Quebec. J Occup Med 32:869–872.
  • Thorne BM, Donohoe T, Lin KN, Lyon S, Medeiros DM, Weaver ML. (1986). Aluminum ingestion and behavior in the Long-Evans rat. Physiol Behav 36:63–67.
  • Thurston H, Gilmore GR, Swales JD. (1972). Aluminium retention and toxicity in chronic renal failure. Lancet 1:881–883.
  • Tosti A, Vincenzi C, Peluso AM. (1990). Accidental diagnosis of aluminium sensitivity with Finn Chambers. Contact Derm 23:48–49.
  • Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, Di Giulio S, Drüeke T. (1983). Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies. Clin Nephrol 19:295–298.
  • Townsend MC, Enterline PE, Sussman NB, Bonney TB, Rippey LL. (1985). Pulmonary function in relation to total dust exposure at a bauxite refinery and alumina-based chemical products plant. Am Rev Respir Dis 132:1174–1180.
  • Trapp GA, Miner GD, Zimmerman RL, Mastri AR, Heston LL. (1978). Aluminum levels in brain in Alzheimer’s disease. Biol Psychiatry 13:709–718.
  • Tremblay C, Armstrong B, Thériault G, Brodeur J. (1995). Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Ind Med 27:335–348.
  • Trippi F, Botto N, Scarpato R, Petrozzi L, Bonuccelli U, Latorraca S, Sorbi S, Migliore L. (2001). Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer’s disease patients. Mutagenesis 16:323–327.
  • Troncoso JC, Hoffman PN, Griffin JW, Hess-Kozlow KM, Price DL. (1985). Aluminum intoxication: a disorder of neurofilament transport in motor neurons. Brain Res 342:172–175.
  • Trompeter RS, Polinsky MS, Andreoli SA, Fennell RS. (1986). Neurologic complications of renal failure. Am J Kidney Dis 7:318–323.
  • Tsou VM, Young RM, Hart MH, Vanderhoof JA. (1991). Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics 87:148–151.
  • Turgut G, Kaptanoglu B, Turgut S, Enli Y, Genç O. (2004). Effects of chronic aluminum administration on blood and liver iron-related parameters in mice. Yonsei Med J 45:135–139.
  • Türkez H, Sisman T. (2007). Anti-genotoxic effect of hydrated sodium calcium aluminosilicate on genotoxicity to human lymphocytes induced by aflatoxin B1. Toxicol Ind Health 23:83–89.
  • Turnquest EM, Hallenbeck WH. (1991). Blood aluminum levels as a function of aluminum intake from drinking water. Bull Environ Contam Toxicol 46:554–560.
  • US Environmental Protection Agency (USEPA). (1984). Drinking Water Criteria Document for Aluminum. Cincinnati: Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office for the Office of Drinking Water, Washington, D.C.
  • US Environmental Protection Agency (USEPA). (1987a). Health effects assessment for aluminum. ECAO-CIN-H114, February.
  • US Environmental Protection Agency (USEPA). (1987b). Federal Register 52(130): 25724–25725 (Wednesday, July 8).
  • US Environmental Protection Agency (USEPA). 1988. Federal Register 53(14): 1894 (Friday, January 22, 1988).
  • US Environmental Protection Agency (USEPA). (1991). National primary drinking water regulations − Synthetic organic chemicals and inorganic chemicals; Monitoring for unregulated contaminants; National primary drinking water regulations implementation; National secondary drinking water regulations. Final rule. Federal Register 56(20):3526–3614.
  • US Environmental Protection Agency (USEPA). (2002). A review of the reference dose and reference concentration process. EPA/630/P-02/002F. 01 Dec 2002. US EPA Risk Assessment Forum, Washington DC Available at: http://www.epa.gov/raf/publications/review-dose.htm
  • US Environmental Protection Agency (USEPA). 2010. U.S. Code of Federal Regulations, Title 40. U.S. Environmental Protection Agency. (July 1).
  • U.S. Food and Drug Administration. (2010b). U.S. Code of Federal Regulations, Title 21. (Food and Drugs). Part 84 Direct food substances affirmed as generally recognized as safe (GRAS). U.S. Department of Health and Human Services, Food and Drug Administration. Available at: http://w.w.w.access.gpo.gov/nara/cfr/waisidx_98/21cfr184_98.html.
  • US Geological Survey (USGS). (2006). US Geological Survey Minerals Yearbook: Aluminum. Available at: http://minerals.usgs.gov/minerals/pubs/commodity/aluminum/alumimyb05.pdf
  • van Boxtel MP, Paas FG, Houx PJ, Adam JJ, Teeken JC, Jolles J. (1997). Aerobic capacity and cognitive performance in a cross-sectional aging study. Med Sci Sports Exerc 29:1357–1365.
  • Van der Voet GB, De Wolff FA. (1987). The effect of di- and trivalent iron on the intestinal absorption of aluminum in rats. Toxicol Appl Pharmacol 90:190–197.
  • van der Voet GB, de Wolff FA. (1986-87). Intestinal absorption of aluminum from antacids: A comparison between hydrotalcite and algeldrate. J Toxicol Clin Toxicol 24:545–553
  • Veien NK, Hattel T, Justesen O, Nørholm A. (1986). Aluminium allergy. Contact Derm 15:295–297.
  • Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E. (2005). Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey. Vaccine 23:1359–1367.
  • Vermeer DE, Frate DA. (1979). Geophagia in rural Mississippi: environmental and cultural contexts and nutritional implications. Am J Clin Nutr 32:2129–2135.
  • Vick KE, Johnson CA. (1985). Aluminum-related osteomalacia in renal-failure patients. Clin Pharm 4:434–439.
  • Viseras C, Meeten GH, Lopez-Galindo A. (1999). Pharmaceutical grade phyllosilicate dispersions: the influence of shear history on floc structure. Int J Pharm 182:7–20.
  • Vittori D, Nesse A, Pérez G, Garbossa G. (1999). Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium. J Inorg Biochem 76:113–120.
  • Vukicevic S, Krempien B, Stavljenic A. (1987). Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. J Bone Miner Res 2:533–545.
  • Walker VR, Sutton RA, Meirav O, Sossi V, Johnson R, Klein J, Fink D, Middleton R. (1994). Tissue disposition of 26aluminum in rats measured by accelerator mass spectrometry. Clin Invest Med 17:420–425.
  • Walton JR. (2006). Aluminum in hippocampal neurons from humans with Alzheimer’s disease. Neurotoxicology 27:385–394.
  • Walton J, Tuniz C, Fink D, Jacobsen G, Wilcox D. (1995). Uptake of trace amounts of aluminum into the brain from drinking water. Neurotoxicology 16:187–190.
  • Wang JS, Luo H, Billam M, Wang Z, Guan H, Tang L, Goldston T, Afriyie-Gyawu E, Lovett C, Griswold J, Brattin B, Taylor RJ, Huebner HJ, Phillips TD. (2005). Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans. Food Addit Contam 22:270–279.
  • Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN. (1978). Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet 1:841–845.
  • Waxweiler RJ, Zumwalde RD, Ness GO, Brown DP. (1988). A retrospective cohort mortality study of males mining and milling attapulgite clay. Am J Ind Med 13:305–315.
  • Weberg R, Berstad A. (1986). Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. Eur J Clin Invest 16:428–432.
  • Weberg R, Berstad A, Ladehaug B, Thomassen Y. (1985). Are aluminum containing antacids during pregnancy safe? Acta Pharmacol Toxicol, 59 (Suppl. VII), 63–65.
  • Wettstein A, Aeppli J, Gautschi K, Peters M. (1991). Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water. Int Arch Occup Environ Health 63:97–103.
  • White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC, Basha MR. (2007). New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225:1–27.
  • White DM, Longstreth WT Jr, Rosenstock L, Claypoole KH, Brodkin CA, Townes BD. (1992). Neurologic syndrome in 25 workers from an aluminum smelting plant. Arch Intern Med 152:1443–1448.
  • Wide M. (1984). Effect of short-term exposure to five industrial metals on the embryonic and fetal development of the mouse. Environ Res 33:47–53.
  • Wilcock LK, Francis JN, Durham SR. (2004). Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy 34:1373–1378.
  • Wiles M, Huebner H, Afriyie-Gyawu E, Taylor R, Bratton G, Phillips T. (2004). Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. J Toxicol Environ Health Part A 67:863–874.
  • Wilhelm M, Zhang XJ, Hafner D, Ohnesorge FK. (1992). Single-dose toxicokinetics of aluminum in the rat. Arch Toxicol 66:700–705.
  • Wills MR, Hewitt CD, Sturgill BC, Savory J, Herman MM. (1993). Long-term oral or intravenous aluminum administration in rabbits. I. Renal and hepatic changes. Ann Clin Lab Sci 23:1–16.
  • Wills MR, Savory J. (1985). Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect 63:141–147.
  • Wilson JW. (1953a). Nutritional deficiency produced in the mouse by feeding bentonite. J Natl Cancer Inst 14:57–63.
  • Wilson JW. (1953b). Hepatomas in mice on a diet containing bentonite. J Natl Cancer Inst 14:65–75.
  • Wilson JW. (1954). Hepatomas produced in mice by feeding betonite in the diet. Ann N Y Acad Sci 57:678–687.
  • Winney RJ, Cowie JF, Robson JS. (1986). Role of plasma aluminum in the detection and prevention of aluminum toxicity. Kidney Int Suppl 18:S91–S95.
  • Wisniewski HM, K. Iqbal K, McDermott JR. (1979). Aluminum-induced neurofibrillary changes: Its relationship to senile dementia of the Alzheimer type. Neurotoxicology, 1, 121–124.
  • Wisniewski HM, Sturman JA, Shek JW. (1980). Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model. Ann Neurol 8:479–490.
  • Wong MH, Fung KF, Carr HP. (2003). Aluminium and fluoride contents of tea, with emphasis on brick tea and their health implications. Toxicol Lett 137:111–120.
  • Woodson GC. (1998). An interesting case of osteomalacia due to antacid use associated with stainable bone aluminum in a patient with normal renal function. Bone 22:695–698.
  • World Health Organization (WHO). (1984). Guidelines for Drinking Water Quality. Volume 1: Recommendations. Lyon: World Health Organization, 80.
  • Xu ZC, Tang JP, Xu ZX, Melethil S. (1992). Kinetics of aluminum in rats. IV: Blood and cerebrospinal fluid kinetics. Toxicol Lett 63:7–12.
  • Yang JD, Feng GY, Zhang J, Cheung J, St Clair D, He L, Ichimura K. (2003). Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer’s disease in the Chinese population. Neurosci Lett 350:25–28.
  • Yano I, Yoshida S, Uebayashi Y, Yoshimasu F, Yase Y. (1989). Degenerative changes in the central nervous system of Japanese monkeys induced by oral administration of aluminum salt. Biomed Res, 10, 33–41.
  • Yokel RA. (1984). Toxicity of aluminum exposure during lactation to the maternal and suckling rabbit. Toxicol Appl Pharmacol 75:35–43.
  • Yokel RA. (1985). Toxicity of gestational aluminum exposure to the maternal rabbit and offspring. Toxicol Appl Pharmacol 79:121–133.
  • Yokel RA. (1987). Toxicity of aluminum exposure to the neonatal and immature rabbit. Fundam Appl Toxicol 9:795–806.
  • Yokel RA. (2000). The toxicology of aluminum in the brain: a review. Neurotoxicology 21:813–828.
  • Yokel RA, Allen DD, Ackley DC. (1999). The distribution of aluminum into and out of the brain. J Inorg Biochem 76:127–132.
  • Yokel RA, Florence RL. (2006). Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology 227:86–93.
  • Yokel RA, McNamara PJ. (1985). Aluminum bioavailability and disposition in adult and immature rabbits. Toxicol Appl Pharmacol 77:344–352.
  • Yokel RA, McNamara PJ. (1988). Influence of renal impairment, chemical form, and serum protein binding on intravenous and oral aluminum kinetics in the rabbit. Toxicol Appl Pharmacol 95:32–43.
  • Yokel RA, McNamara PJ. (2001). Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159–167.
  • Yokel RA, Rhineheimer SS, Brauer RD, Sharma P, Elmore D, McNamara PJ. (2001a). Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness. Toxicology 161:93–101.
  • Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ. (2001b). Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure. Toxicol Sci 64:77–82.
  • Yousef MI, Kamel KI, El-Guendi MI, El-Demerdash FM. (2007). An in vitro study on reproductive toxicity of aluminium chloride on rabbit sperm: the protective role of some antioxidants. Toxicology 239:213–223.
  • Zafar TA, Teegarden D, Ashendel C, Dunn MA, Weaver CM. (2004). Aluminum negatively impacts calcium utilization and bone in calcium-deficient rats. Nutr Res, 24, 243–259.
  • Zaid MR, Hasan M, Khan AA. (1995). Attapulgite in the treatment of acute diarrhoea: a double-blind placebo-controlled study. J Diarrhoeal Dis Res 13:44–46.
  • Zaid MR, Hasan M, Khan AA. (1995). Attapulgite in the treatment of acute diarrhea: a double-blind placebo-controlled study. J Diarrhoeal Dis Res, 13, 44–46.
  • Zatta P, Zambenedetti P, Reusche E, Stellmacher F, Cester A, Albanese P, Meneghel G, Nordio M. (2004). A fatal case of aluminium encephalopathy in a patient with severe chronic renal failure not on dialysis. Nephrol Dial Transplant 19:2929–2931.
  • Zelic O, Dimitrijevic B, Vasilijevska M, Dujic A, Lekic PC. (1998). A dental implant: aluminium trioxide exhibited no effect on mouse reproductive and mutanogenic potential. J Clin Periodontol 25:892–896.
  • Zheng YX, Liang YX. (1998). The antagonistic effects of L-dopa and eserine on Al-induced neurobehavioral deficits in rats. Biomed Environ Sci 11:321–330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.